https://sofinnovapartners.com/team/julia-metzger2026-02-02T10:13:17Z https://sofinnovapartners.com/news/elicit-plant-validates-on-a-large-scale-the-performance-of-its-best-a-product-for-corn-that-reduces-crops-water-consumption-and-addresses-the-challenges-of-climate-change2023-02-17T13:03:22Z https://sofinnovapartners.com/team/hortense-fouilland2024-08-05T14:57:03Z https://sofinnovapartners.com/team/sylvie-chapoy2023-09-08T07:42:13Z https://sofinnovapartners.com/portfolio/tulyp-medical2025-11-04T06:59:10Z https://sofinnovapartners.com/portfolio/mozart-therapeutics2022-01-03T11:31:24Z https://sofinnovapartners.com/news/nuage-therapeutics-appoints-dr-stuart-hughes-as-ceo-and-vanessa-malier-as-chair2025-08-13T15:12:31Z https://sofinnovapartners.com/news/dna-script-strengthens-its-management-team-with-the-appointment-of-bruno-poddevin-as-senior-vice-president-of-business-and-corporate-development2024-08-08T16:17:13Z https://sofinnovapartners.com/news/alia-therapeutics-appoints-adel-nada-as-independent-board-director2024-08-08T13:27:26Z https://sofinnovapartners.com/news/mediar-advances-first-in-class-fibrosis-portfolio-to-the-clinic-with-first-cohort-dosing-in-phase-1-trial-of-mtx-463-and-establishes-clinical-advisory-board2025-08-29T07:07:25Z https://sofinnovapartners.com/news/Johnson & Johnson Completes Acquisition of Shockwave Medical2025-08-27T14:38:35Z https://sofinnovapartners.com/news/inventiva-appoints-andrew-obenshain-as-chief-executive-officer2025-10-02T10:40:41Z https://sofinnovapartners.com/portfolio/werewool2023-05-10T10:24:16Z https://sofinnovapartners.com/news/brightheart-welcomes-michael-butchko-as-an-independent-board-member2024-01-30T10:57:29Z https://sofinnovapartners.com/portfolio/bioclec2025-03-18T05:07:57Z https://sofinnovapartners.com/news/abivax-announces-patient-reported-outcomes-data-from-the-phase-3-abtect-induction-trials-of-obefazimod-demonstrating-significant-improvements-in-quality-of-life-for-patients-with-moderate-to-severely2025-11-21T10:17:08Z https://sofinnovapartners.com/news/shockwave-medical-announces-agreement-to-acquire-neovasc2023-01-18T06:05:06Z https://sofinnovapartners.com/news/inspirna-announces-appointment-of-karim-benhadji-m-d-as-chief-medical-officer-and-retirement-of-robert-wasserman-m-d2025-08-29T06:47:46Z https://sofinnovapartners.com/news/disco-pharmaceuticals-appoints-ajla-hrle-as-chief-business-officer2025-08-14T14:53:44Z https://sofinnovapartners.com/news/glycoera-ag-appoints-ganesh-v-kaundinya-as-president-and-chief-executive-officer2022-05-03T12:10:15Z https://sofinnovapartners.com/news/sofinnova-partners-portfolio-company-amolyt-pharma-to-be-acquired-by-astrazeneca2025-08-29T08:29:57Z https://sofinnovapartners.com/team/anne-sophie-castaigne2025-02-13T10:06:43Z https://sofinnovapartners.com/news/microphyt-appoints-two-new-directors-and-confirms-its-cocus-on-sustainable-value-creation-with-a-new-esg-advisory-committee2023-03-27T09:10:58Z https://sofinnovapartners.com/news/handbook-for-impact-accountability-in-vc-developed-by-coalition-of-impact-driven-funds2025-08-22T15:23:09Z https://sofinnovapartners.com/news/comet-bio-announces-usd22m-round-of-equity-financing2024-08-08T16:29:29Z https://sofinnovapartners.com/news/purespring-therapeutics-receives-uk-cta-approval-for-phase-i-ii-clinical-trial-of-ps-002-in-patients-with-primary-iga-nephropathy-igan2025-08-12T11:29:08Z https://sofinnovapartners.com/team/artur-mocanu2025-12-10T11:45:00Z https://sofinnovapartners.com/portfolio/mironid2022-01-03T11:31:24Z https://sofinnovapartners.com/news/arzeda-secures-usd38m-in-oversubscribed-funding-round-to-advance-protein-design-commercialization-efforts2025-08-25T13:07:57Z https://sofinnovapartners.com/news/mediar-therapeutics-announces-usd105-million-financing-to-advance-portfolio-of-first-in-class-fibrosis-therapies2023-03-15T09:36:01Z https://sofinnovapartners.com/portfolio/gfbiochemicals2025-02-20T15:01:30Z https://sofinnovapartners.com/news/betteromics-raises-usd20-million-in-series-a-financing-led-by-sofinnova-partners-and-triatomic-capital2023-10-26T04:00:17Z https://sofinnovapartners.com/team/simon-turner2025-12-16T22:15:35Z https://sofinnovapartners.com/news/the-secrets-to-50-years-of-success-in-life-sciences-investment2022-03-21T18:13:59Z https://sofinnovapartners.com/news/brightheart-sets-new-standard-in-prenatal-chd-screening-with-landmark-study-published-in-obstetrics-and-gynecology2025-09-05T08:52:35Z https://sofinnovapartners.com/news/tissium-appoints-maria-sainz-as-independent-board-member2022-07-13T08:48:54Z https://sofinnovapartners.com/news/abivax-announces-closing-of-usd747-5-million-public-offering2025-08-12T13:37:10Z https://sofinnovapartners.com/news/crescendo-biologics-announces-that-zai-lab-has-initiated-a-global-phase-2-clinical-trial-evaluating-zl-1102-humabody-r-cb001-as-a-topical-treatment-for-psoriasis2025-08-26T09:50:30Z https://sofinnovapartners.com/news/production-operations-at-afyren-neoxy-plant-make-significant-progress-with-first-lots-delivered2023-06-08T10:10:02Z https://sofinnovapartners.com/news/sensorion-completes-a-private-placement-of-eur35-million-subscribed-by-leading-us-and-european-biotech-investors2023-08-21T10:01:41Z https://sofinnovapartners.com/team/anis-belmili2026-02-02T10:05:19Z https://sofinnovapartners.com/news/afyren-begins-new-phase-of-industrial-strategy-as-first-plant-afyren-neoxy-achieves-continuous-production2025-08-12T14:17:44Z https://sofinnovapartners.com/news/corwave-announces-successful-completion-of-6-month-chronic-in-vivo-study-paving-the-way-for-clinical-trial-initiation2025-08-13T14:52:04Z https://sofinnovapartners.com/news/gradient-denervation-technologies-announces-appointment-of-martin-grasse-as-chief-executive-officer2022-04-07T07:31:39Z https://sofinnovapartners.com/portfolio/muna-therapeutics2022-01-03T11:31:24Z https://sofinnovapartners.com/news/mainstay-medical-announces-receipt-of-fda-approval-for-mri-labeling-on-reactiv8-r-restorative-neurostimulation-system2024-02-27T09:23:22Z https://sofinnovapartners.com/news/ceo-spotlight-thierry-abribat-s-third-straight-win2025-08-26T07:59:44Z https://sofinnovapartners.com/features/2024-impact-report-delivering-impact2025-08-28T16:05:18Z https://sofinnovapartners.com/news/crescendo-biologics-secures-usd32m-and-announces-expansion-of-cb307-phase-1b-trial-in-psma-solid-tumors2023-07-25T15:30:16Z https://sofinnovapartners.com/news/abivax-announces-full-year-2025-financial-results-and-provides-business-updates2026-04-13T13:25:42Z https://sofinnovapartners.com/news/recor-medical-and-otsuka-medical-devices-announce-positive-vote-from-u-s-food-and-drug-administration-fda-advisory-committee-meeting-on-the-paradise-tm-ultrasound-renal-denervation-system-for-the2023-08-24T07:05:15Z https://sofinnovapartners.com/news/inotrem-announces-positive-outcome-of-its-phase-ii-astonish-trial-in-septic-shock-patients-demonstrating-efficacy-of-nangibotide2022-10-17T04:51:37Z https://sofinnovapartners.com/news/moon-surgical-completes-first-in-human-clinical-study-with-its-maestro-tm-surgical-robotics-system2022-12-13T13:47:30Z https://sofinnovapartners.com/news/fda-approves-limflow-system-in-patients-with-chronic-limb-threatening-ischemia-and-no-suitable-endovascular-or-surgical-revascularization-options2023-09-12T13:25:34Z https://sofinnovapartners.com/team/matthieu-coutet2025-12-16T22:09:24Z https://sofinnovapartners.com/news/latent-labs-secures-usd50m-in-funding-to-realize-the-potential-of-ai-powered-programmable-biology2025-08-14T14:06:53Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-appoints-lisa-m-olson-as-ceo-and-announces-clinical-trial-progress-with-ent0012024-01-23T10:51:39Z https://sofinnovapartners.com/news/inventiva-announces-a-eur20-1-million-issuance-of-royalty-certificates2025-08-26T07:56:39Z https://sofinnovapartners.com/news/biocortex-announces-strategic-partnership-with-cd-biopharma-to-accelerate-global-precision-oncology2025-12-05T09:33:00Z https://sofinnovapartners.com/news/bioptimus-hits-usd76m-funding-milestone-and-prepares-to-launch-groundbreaking-foundation-model-for-biology2025-08-14T14:14:47Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-mary-mccarthy-as-partner-for-the-firm-s-industrial-biotech-strategy2023-04-20T10:30:12Z https://sofinnovapartners.com/news/nitrase-therapeutics-expands-leadership-team-with-accomplished-drug-discovery-and-development-executives2022-07-07T05:19:38Z https://sofinnovapartners.com/news/iomx-therapeutics-receives-regulatory-approval-of-clinical-trial-application-for-iomx-06752025-08-13T15:01:16Z https://sofinnovapartners.com/strategy/md-start2025-12-12T18:08:05Z https://sofinnovapartners.com/news/corwave-to-set-up-its-manufacturing-facility-and-expand-to-a-new-site-next-to-paris2022-03-18T17:27:48Z https://sofinnovapartners.com/news/inspirna-to-present-phase-1b-rgx-202-01-clinical-trial-data-at-the-2022-esmo-world-congress-on-gastrointestinal-cancer2022-06-28T17:23:36Z https://sofinnovapartners.com/news/noema-pharma-extends-series-b-financing-round-closing-at-chf130-million-usd147-million2025-08-22T15:13:12Z https://sofinnovapartners.com/news/asahi-kasei-to-acquire-calliditas-therapeutics-ab-to-accelerate-growth-as-a-global-healthcare-company2025-08-27T14:41:15Z https://sofinnovapartners.com/portfolio/elevara-medicines2025-10-22T05:23:57Z https://sofinnovapartners.com/news/nodthera-s-nlrp3-inhibitor-nt-0796-meets-primary-endpoint-of-inflammation-reversal-in-phase-ib-iia-trial-in-obese-subjects-with-cardiovascular-risk2024-07-01T10:37:56Z https://sofinnovapartners.com/portfolio/dmc-biotechnologies2022-01-03T11:31:24Z https://sofinnovapartners.com/news/aavantgarde-bio-appoints-ram-palanki-as-chairman-of-its-board-of-directors2022-03-31T16:23:06Z https://sofinnovapartners.com/news/tulyp-medical-emerges-from-sofinnova-s-medtech-accelerator-and-announces-fda-submission-following-initial-first-in-human-use2025-11-04T07:01:18Z https://sofinnovapartners.com/news/sofinnova-partners-chair-sees-opportunity-on-the-horizon2023-01-08T06:50:59Z https://sofinnovapartners.com/news/sofinnova-s-newest-partners-discuss-their-career-paths2024-04-24T14:51:36Z https://sofinnovapartners.com/news/glycoera-ag-expands-board-of-directors-and-appoints-georges-gemayel-ph-d-as-chair2022-07-13T07:56:11Z https://sofinnovapartners.com/portfolio/Neurent Medical2026-02-11T06:49:34Z https://sofinnovapartners.com/team/sandy-diep2023-09-07T16:46:45Z https://sofinnovapartners.com/news/inventiva-announces-that-screening-in-the-nativ3-phase-iii-clinical-trial-evaluating-lanifibranor-in-nash-has-resumed2024-08-02T10:35:42Z https://sofinnovapartners.com/news/noema-pharma-appoints-volker-knappertz-m-d-as-executive-vice-president-of-research-and-development2025-08-22T15:11:07Z https://sofinnovapartners.com/news/AAVantgarde appoints Ms. Lauren Kaskiel as Chief Business Officer2025-08-25T12:40:11Z https://sofinnovapartners.com/team/gabriela-sachet-fernandez2025-07-07T14:56:22Z https://sofinnovapartners.com/news/tissium-receives-fda-de-novo-authorization-for-coaptium-r-connect-in-atraumatic-sutureless-peripheral-nerve-repair2025-08-12T14:06:49Z https://sofinnovapartners.com/news/the-franche-comte-polyclinic-and-moon-surgical-showcase-the-maestro-system-s-simplicity-and-ease-of-use2023-12-05T09:21:52Z https://sofinnovapartners.com/news/neurent-medical-raises-eur62-5-million-in-oversubscribed-series-c-financing-to-accelerate-neuromark-r-commercial-expansion-to-treat-chronic-rhinitis2026-02-11T15:02:46Z https://sofinnovapartners.com/news/calliditas-announces-primary-endpoint-successfully-met-in-phase-3-nefigard-trial-evaluating-nefecon-r-in-iga-nephropathy2023-03-13T11:13:29Z https://sofinnovapartners.com/news/signadori-bio-appoints-dr-selwyn-ho-mb-bs-as-chief-executive-officer-to-lead-company-into-next-stage-of-growth2026-03-31T07:17:14Z https://sofinnovapartners.com/news/afyren-adds-new-hires-to-support-growth-in-france-and-expansion-abroad2023-01-10T12:46:24Z https://sofinnovapartners.com/news/micropep-technologies-appoints-georg-goeres-as-ceo-to-lead-next-phase-of-commercial-growth2025-08-12T12:45:37Z https://sofinnovapartners.com/news/amolyt-pharma-announces-research-agreement-and-licensing-option-with-xoma2023-01-25T14:33:23Z https://sofinnovapartners.com/portfolio/alia-therapeutics2022-01-03T11:31:24Z https://sofinnovapartners.com/team/sara-saoud2024-10-17T12:00:58Z https://sofinnovapartners.com/news/alia-therapeutics-names-letizia-goretti-as-chief-executive-officer2023-05-05T08:31:31Z https://sofinnovapartners.com/news/tissium-announces-u-s-commercial-launch-of-coaptium-r-connect-and-strategic-governance-evolution2025-08-12T13:38:32Z https://sofinnovapartners.com/news/mission-therapeutics-announces-us-fda-approval-to-initiate-phase-ii-clinical-trial-of-its-lead-asset-mtx652-in-acute-kidney-injury2024-08-06T13:59:59Z https://sofinnovapartners.com/news/johnson-and-johnson-to-acquire-shockwave-medical2025-08-29T07:59:46Z https://sofinnovapartners.com/team/anna-belousova2024-08-05T11:17:30Z https://sofinnovapartners.com/news/tom-burt-partner-at-sofinnova-partners-speaks-at-edison-group-s-open-house-global-healthcare-event2023-09-05T12:52:27Z https://sofinnovapartners.com/news/Arzeda to Lead Major NSF-Funded Initiative Advancing Cell-Free Manufacturing Through AI-Designed Enzymes2025-09-19T14:47:00Z https://sofinnovapartners.com/news/reflexion-announces-real-world-evidence-outcomes-registry-to-evaluate-treatment-impact-on-all-stages-of-cancer2022-05-04T08:28:15Z https://sofinnovapartners.com/news/sofinnova-partners-announces-new-investment-in-nanophoria-developer-of-an-innovative-non-viral-drug-delivery-platform2022-05-13T04:59:13Z https://sofinnovapartners.com/news/abivax-provides-operational-and-key-program-update2025-08-26T08:51:44Z https://sofinnovapartners.com/news/we-build-them-to-be-great-companies-anne-osdoit-tells-in-vivo2022-04-12T08:46:56Z https://sofinnovapartners.com/news/moon-surgical-announces-appointment-of-mark-toland-as-independent-board-member2022-11-15T17:14:29Z https://sofinnovapartners.com/news/nodthera-announces-appointment-of-greg-chow-as-chief-financial-and-business-officer2025-08-25T17:13:26Z https://sofinnovapartners.com/news/synthace-appoints-dr-donald-deieso-as-new-board-chair2023-09-05T12:53:40Z https://sofinnovapartners.com/news/inventiva-announces-the-publication-in-nature-communications-of-additional-results-from-native-phase-iib-clinical-trial-demonstrating-improvement-of-markers-of-cardiometabolic-health-in-patients-with2024-08-02T17:52:31Z https://sofinnovapartners.com/news/nodthera-s-nlrp3-inhibitor-nt-0796-reverses-neuroinflammation-in-parkinson-s-disease-phase-ib-iia-trial2024-04-04T08:42:33Z https://sofinnovapartners.com/news/mozart-therapeutics-raises-usd25-million-in-expanded-series-a-financing-to-support-clinical-development-of-first-in-class-cd8-treg-modulators-for-the-treatment-of-autoimmune-diseases2023-06-09T05:02:42Z https://sofinnovapartners.com/news/hitgen-announces-research-agreement-with-nitrase-therapeutics-focused-on-dna-encoded-library-based-drug-discovery2022-12-16T14:37:44Z https://sofinnovapartners.com/news/AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting2025-08-13T10:01:29Z https://sofinnovapartners.com/news/t-therapeutics-raises-gbp48-million-series-a-for-development-of-next-generation-tcr-therapeutics-to-transform-cancer-treatment2023-11-15T11:13:33Z https://sofinnovapartners.com/legal-terms2026-04-09T12:46:37Z https://sofinnovapartners.com/portfolio/artios-pharma2022-01-03T11:31:24Z https://sofinnovapartners.com/news/kiro-cutting-edge-digital-medicine-company-raises-eur13-8-million-in-series-a-funding-led-by-sofinnova-partners2023-03-28T03:31:30Z https://sofinnovapartners.com/news/brits-call-for-tech-revolution-to-tackle-nhs-wait-times-deepc-joins-forces-with-bt2023-08-25T16:04:23Z https://sofinnovapartners.com/news/maestro-surgical-robotics-system-by-moon-surgical-now-ce-marked2023-04-12T19:13:25Z https://sofinnovapartners.com/strategy/biovelocita2026-04-15T09:57:13Z https://sofinnovapartners.com/news/asahi-kasei-completes-the-recommended-public-cash-offer-and-becomes-the-owner-of-93-30-per-cent-of-all-shares-in-calliditas2025-08-25T16:54:55Z https://sofinnovapartners.com/news/sustainable-performance-fibers-company-werewool-raises-usd3-7-million-led-by-material-impact-and-sofinnova-partners2023-05-10T10:38:00Z https://sofinnovapartners.com/news/abivax-announces-positive-phase-3-results-from-both-abtect-8-week-induction-trials-investigating-obefazimod-its-first-in-class-oral-mir-124-enhancer-in-moderate-to-severely-active-ulcerative-colitis2025-08-12T13:40:40Z https://sofinnovapartners.com/news/moon-surgical-expands-to-gynecological-surgery2024-04-04T08:25:47Z https://sofinnovapartners.com/news/myricx-enters-into-antibody-license-agreement-with-biocytogen2023-09-08T11:24:38Z https://sofinnovapartners.com/features/sofinnova-partners-industrial-biotech-strategy2023-03-06T11:12:11Z https://sofinnovapartners.com/portfolio/hemab-therapeutics2025-10-27T10:34:31Z https://sofinnovapartners.com/news/micropep-raises-usd29m-in-series-b-funding-and-unveils-krisalix-its-proprietary-discovery-platform2025-08-25T17:16:42Z https://sofinnovapartners.com/team/javier-nunez-vicandi2024-08-05T10:58:33Z https://sofinnovapartners.com/privacy-notice2023-12-05T11:10:10Z https://sofinnovapartners.com/news/highlife-receives-ide-approval-to-initiate-us-pivotal-clinical-study-for-treatment-of-mitral-regurgitation2025-08-27T14:32:28Z https://sofinnovapartners.com/news/digital-medicine-pioneer-deepc-announces-eur12-million-series-a-round-led-by-sofinnova-partners2023-03-28T03:12:02Z https://sofinnovapartners.com/news/deepc-closes-series-a-extension-to-accelerate-global-deployment-of-healthcare-ai-bringing-total-funding-to-usd30m2025-08-26T07:28:52Z https://sofinnovapartners.com/news/aavantgarde-announces-fda-orphan-drug-designation-and-uk-cta-approval-for-aavb-039-for-the-treatment-of-stargardt-disease2025-11-21T10:21:33Z https://sofinnovapartners.com/portfolio/prometheus-materials2022-06-06T13:45:12Z https://sofinnovapartners.com/news/limflow-raises-usd40-million-eur36-million-in-series-d-financing2022-04-05T12:48:55Z https://sofinnovapartners.com/news/micropep-and-corteva-announce-multi-year-research-collaboration-to-advance-sustainable-biocontrol-solutions2025-06-18T14:42:02Z https://sofinnovapartners.com/news/asceneuron-awarded-second-grant-from-the-michael-j-fox-foundation-for-accelerated-research-into-novel-parkinson-s-disease-therapies2022-05-04T09:23:08Z https://sofinnovapartners.com/news/chroma-medicine-strengthens-leadership-with-the-appointment-of-biotech-business-leader-michael-a-kelly-to-its-board-of-directors2024-08-08T14:33:25Z https://sofinnovapartners.com/news/comet-opens-world-s-first-high-purity-arabinoxylan-dietary-fiber-production-facility2024-08-08T16:31:15Z https://sofinnovapartners.com/news/techbio-startup-cure51-selects-10x-genomics-visium-hd-for-new-drug-discovery-initiative2025-08-22T15:32:08Z https://sofinnovapartners.com/news/aavantgarde-bio-announces-fda-fast-track-designation-for-aavb-039-for-the-treatment-of-stargardt-disease2025-08-12T11:05:20Z https://sofinnovapartners.com/news/landmark-new-england-journal-of-medicine-publication-reports-positive-results-from-promise-ii-pivotal-trial-showing-that-limflow-system-saves-most-patients-with-end-stage-peripheral-artery-disease2023-03-30T13:00:53Z https://sofinnovapartners.com/news/nanophoria-bioscience-secures-eur83-5-million-series-a-to-advance-breakthrough-heart-failure-therapy-and-expand-portfolio-for-novel-nano-in-micro-delivery-platform2026-02-17T17:07:12Z https://sofinnovapartners.com/news/Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZITM, the First and Only Combination Eye Drop Approved to Treat Presbyopia2026-01-29T07:36:32Z https://sofinnovapartners.com/news/disco-pharmaceuticals-launches-as-the-surfaceome-company-with-eur-20-million-in-seed-financing2024-01-16T16:30:58Z https://sofinnovapartners.com/news/global-debut-in-an-asc-setting-at-surgeon-s-point-surgery-center-for-moon-surgical-s-maestro-system2025-08-14T14:41:10Z https://sofinnovapartners.com/news/bon-vivant-the-french-leader-in-animal-free-dairy-proteins-closes-a-eur15m-financing-round-led-by-sofinnova-partners-and-sparkfood-to-accelerate-its-precision-fermentation-offering-for-the-dairy2023-10-12T09:49:23Z https://sofinnovapartners.com/news/cure51-launches-nhs-approved-study-with-cambridge-university-hospitals-and-seven-other-leading-uk-oncology-institutions-to-unlock-cancer-survival-secrets2025-08-22T15:25:21Z https://sofinnovapartners.com/news/sangamo-therapeutics-and-chroma-medicine-announce-option-and-license-agreement-to-evaluate-and-develop-zinc-finger-proteins-for-epigenetic-editing2024-08-08T14:34:01Z https://sofinnovapartners.com/news/lucia-faccio-comments-on-the-increased-interest-from-investors-in-the-rare-diseases-space2022-03-07T14:05:19Z https://sofinnovapartners.com/news/asceneuron-welcomes-barbara-angehrn-pavik-as-new-ceo-as-it-gears-up-for-next-phase-of-growth2023-10-06T15:47:49Z https://sofinnovapartners.com/news/sofinnova-partners-launches-digital-medicine-strategy-to-back-startups-at-the-intersection-of-biology-data-and-computation2024-02-05T18:16:50Z https://sofinnovapartners.com/news/cedric-moreau-discusses-apollo-deal-on-journal-des-biotechs2022-06-09T14:24:49Z https://sofinnovapartners.com/news/mediar-therapeutics-announces-oversubscribed-usd76-million-series-b-financing-and-clinical-advancement-of-first-in-class-fibrosis-portfolio2026-01-07T15:53:55Z https://sofinnovapartners.com/portfolio/hepta-medical2024-08-09T15:10:12Z https://sofinnovapartners.com/news/pi-cardia-successfully-performs-mitral-valve-splitting-with-shortcut-tm2022-08-23T11:53:38Z https://sofinnovapartners.com/news/tissium-advances-clinical-pipeline-in-hernia-repair-following-first-fda-authorization2025-09-05T08:45:27Z https://sofinnovapartners.com/news/purespring-therapeutics-announce-fda-ind-clearance-for-phase-i-ii-clinical-trial-for-primary-iga-nephropathy-igan2025-08-12T13:55:55Z https://sofinnovapartners.com/team/heloise-percheron2024-09-30T04:59:59Z https://sofinnovapartners.com/news/afyren-announces-signing-of-new-commercial-contract-with-us-nutraceutical-maker2025-08-25T17:03:20Z https://sofinnovapartners.com/portfolio/amolyt-pharma2023-01-06T18:12:55Z https://sofinnovapartners.com/news/gradient-denervation-technologies-enrolls-initial-patient-in-first-in-human-study-of-pulmonary-artery-denervation-technology2023-06-01T11:00:43Z https://sofinnovapartners.com/news/bioptimus-assembles-elite-scientific-advisory-board-to-build-next-gen-ai-models-for-biology2025-09-11T13:12:55Z https://sofinnovapartners.com/news/lucia-faccio-italy-is-a-center-of-excellence-for-biotech2022-04-06T07:32:10Z https://sofinnovapartners.com/news/elevara-medicines-doses-first-patient-in-phase-2b-start-synergy-trial-of-elv001-in-rheumatoid-arthritis-patients-with-incomplete-response-to-tnfi2026-04-13T13:38:34Z https://sofinnovapartners.com/news/world-first-corwave-s-undulating-membrane-heart-pump-implanted-in-first-patient2025-08-12T13:52:42Z https://sofinnovapartners.com/news/gensight-biologics-obtains-funding-of-eur10-million-from-sofinnova-partners-invus-and-upmc-enterprises2023-08-04T04:39:03Z https://sofinnovapartners.com/news/amolyt-pharma-enters-into-definitive-agreement-to-be-acquired-by-astrazeneca2025-08-29T08:30:54Z https://sofinnovapartners.com/news/nodthera-announces-positive-phase-1-study-readouts-for-the-nlrp3-inflammasome-inhibitors-nt-0796-and-nt-02492022-09-22T07:12:03Z https://sofinnovapartners.com/news/sofinnova-partners-and-gustave-roussy-forge-strategic-alliance-to-boost-oncology-startup-acceleration-in-france2023-12-13T07:50:30Z https://sofinnovapartners.com/team/josh-makower-md2025-07-07T14:53:41Z https://sofinnovapartners.com/news/f2g-announces-usd70-million-financing-to-advance-development-and-commercialization-of-new-antifungal-agent-olorofim2022-08-04T07:33:43Z https://sofinnovapartners.com/news/HEPTA Medical secures €5.7 million Series A, led by BPI France to advance minimally invasive lung cancer treatment2025-08-25T16:41:11Z https://sofinnovapartners.com/news/may-health-announces-ce-mark-for-innovative-treatment-for-women-with-pcos-related-infertility2025-12-16T17:15:01Z https://sofinnovapartners.com/news/freya-biosciences-announces-positive-phase-1-first-in-human-data-with-fb301-for-ivf-related-embryo-implantation-failure2026-04-17T14:58:28Z https://sofinnovapartners.com/news/t-therapeutics-announces-series-a-extension-to-usd91-million-to-advance-first-in-class-bispecifics-towards-the-clinic2025-11-13T07:38:42Z https://sofinnovapartners.com/news/May Health Raises $11.7M to Advance its Novel Technology to Treat PCOS-related Infertility2026-04-13T13:39:59Z https://sofinnovapartners.com/news/nodthera-is-first-to-demonstrate-reduction-in-neuroinflammation-in-the-clinic-with-brain-penetrant-nlrp3-inflammasome-inhibitor2023-07-11T14:25:21Z https://sofinnovapartners.com/news/may-health-appoints-seasoned-medtech-executive-colby-holtshouse-as-president-and-ceo2025-08-13T15:45:39Z https://sofinnovapartners.com/news/elicit-plant-awarded-up-to-eur7-5-m-funding-from-the-european-commission-through-the-eic-accelerator-program-for-deep-tech-start-up2022-12-20T15:08:32Z https://sofinnovapartners.com/news/verley-secures-usd38-million-series-a-to-commercialize-high-performance-whey-protein-ingredients-through-precision-fermentation2026-02-24T16:24:00Z https://sofinnovapartners.com/news/ferrer-acquires-worldwide-rights-to-asn90-an-o-glcnacase-inhibitor-from-asceneuron-exclusively-to-treat-progressive-supranuclear-palsy-psp2023-02-23T13:03:40Z https://sofinnovapartners.com/news/papiernik-tells-bloomberg-that-biotech-is-essential-to-pharma-industry2022-06-01T15:17:11Z https://sofinnovapartners.com/news/chroma-medicine-and-nvelop-therapeutics-unite-to-form-nchroma-bio-securing-usd75-million-to-accelerate-genetic-medicines2025-08-22T15:13:39Z https://sofinnovapartners.com/news/t-therapeutics-appoints-theodora-harold-as-chief-executive-officer-reflecting-company-s-ambitious-growth-plans-and-progression-into-therapeutic-development2025-08-13T15:44:12Z https://sofinnovapartners.com/news/bioptimus-and-proscia-collaborate-to-accelerate-ai-innovation-in-scientific-research-and-drug-development-for-improved-patient-care2025-08-22T15:39:55Z https://sofinnovapartners.com/news/highlife-welcomes-stefan-pilz-as-new-chief-executive-officer2025-08-26T09:20:04Z https://sofinnovapartners.com/news/adc-innovator-myricx-bio-appoints-boston-based-mohit-rawat-as-ceo-and-expands-team-in-us-and-uk2025-09-22T07:42:03Z https://sofinnovapartners.com/portfolio/verley-formerly-bon-vivant2025-03-28T16:14:11Z https://sofinnovapartners.com/team/andrew-m-weiss2025-09-04T13:14:44Z https://sofinnovapartners.com/news/sensorion-announces-approval-to-initiate-lead-gene-therapy-candidate-sens-501-otof-gt-into-a-phase-1-2-clinical-trial-in-some-european-countries2024-01-19T11:00:05Z https://sofinnovapartners.com/news/gradient-denervation-technologies-enrolls-first-patient-in-early-feasibility-study-of-pulmonary-artery-denervation-system2024-03-06T15:44:12Z https://sofinnovapartners.com/news/biotalys-obtains-new-fungicide-resistance-class-for-its-first-biofungicide2024-04-02T06:32:21Z https://sofinnovapartners.com/news/glycoera-ag-announces-appointment-of-tanmoy-ganguly-ph-d-as-chief-scientific-officer2022-06-16T13:40:15Z https://sofinnovapartners.com/news/galvanize-therapeutics-raises-usd100-million-in-oversubscribed-series-c-financing-to-transform-the-treatment-of-cancer-and-chronic-lung-disease2025-09-05T08:46:40Z https://sofinnovapartners.com/news/noema-pharma-announces-noe-105-gemlapodect-phase-2a-study-in-tourette-syndrome-met-primary-and-all-key-secondary-endpoints2025-08-25T12:44:01Z https://sofinnovapartners.com/portfolio/mablink-bioscience2024-07-10T10:08:59Z https://sofinnovapartners.com/news/elicit-plant-announces-its-upcoming-us-biosolution-launch-with-demonstrated-20-reduction-of-water-consumption-in-broad-acre-crops2025-08-29T08:52:36Z https://sofinnovapartners.com/team/aishwarya-parthasarathy2025-04-15T14:10:16Z https://sofinnovapartners.com/news/first-finished-products-made-with-recycled-styrene-generated-through-pyrowave-technology2023-09-15T19:50:25Z https://sofinnovapartners.com/news/mainstay-medical-announces-publication-of-clinical-results-comparing-older-patients-and-younger-patients2024-08-05T17:13:35Z https://sofinnovapartners.com/team/ligia-vela-reid2024-09-27T18:43:01Z https://sofinnovapartners.com/team/mano-iyer2025-12-16T22:11:50Z https://sofinnovapartners.com/portfolio/brightheart2023-05-31T06:06:55Z https://sofinnovapartners.com/news/purespring-therapeutics-raises-gbp80-usd105-million-in-a-series-b-financing-to-transform-the-treatment-of-kidney-diseases2025-08-25T12:56:37Z https://sofinnovapartners.com/portfolio/borea-therapeutics2022-01-03T11:31:24Z https://sofinnovapartners.com/news/aavantgarde-appoints-dr-jayashree-sahni-as-chief-medical-officer2025-08-25T16:38:07Z https://sofinnovapartners.com/portfolio/biovelocita2025-07-04T17:49:53Z https://sofinnovapartners.com/news/corwave-announces-the-appointment-of-magalie-durre-che-as-chief-financial-officer2024-08-06T13:32:31Z https://sofinnovapartners.com/news/pi-cardia-receives-fda-breakthrough-device-designation-for-shortcut-tm-first-dedicated-leaflet-modification-device-to-enable-tavr-in-patients-at-risk-of-coronary-obstruction2024-03-06T15:40:27Z https://sofinnovapartners.com/news/calliditas-therapeutics-announces-license-agreement-with-viatris-to-register-and-commercialize-specialty-therapy-for-iga-nephropathy-in-japan2022-12-13T15:50:32Z https://sofinnovapartners.com/news/women-on-both-sides-of-the-pitch-call-meet-at-virtual-round-table2022-02-28T11:41:16Z https://sofinnovapartners.com/news/pincell-announces-the-development-of-a-key-transgenic-mouse-model-and-the-appointment-of-dr-antonino-amato-as-ceo2023-01-19T09:06:20Z https://sofinnovapartners.com/news/moon-surgical-launches-maestro-tm-platform-at-lee-health2025-08-12T13:46:41Z https://sofinnovapartners.com/news/f2g-announces-usd100-million-financing-to-advance-late-stage-development-and-commercialization-of-novel-antifungal-drug-candidate-olorofim-in-the-us2025-08-25T16:31:32Z https://sofinnovapartners.com/news/AAVantgarde Founder and CSO is elected as President of the European Society of Gene and Cell Therapy (ESGCT)2025-08-22T15:36:57Z https://sofinnovapartners.com/news/abivax-announces-successful-oversubscribed-eur49-2-million-crossover-financing-with-top-tier-u-s-and-european-biotech-investors2022-09-05T05:54:11Z https://sofinnovapartners.com/strategy/capital2025-12-12T18:05:49Z https://sofinnovapartners.com/news/cincor-pharma-to-be-acquired-by-astrazeneca2023-01-09T07:52:18Z https://sofinnovapartners.com/news/elicit-plant-accelerates-its-international-expansion-in-response-to-climate-change-and-challenges-in-the-agricultural-sector2025-08-29T06:17:45Z https://sofinnovapartners.com/news/aavantgarde-appoints-dr-peter-k-kaiser-to-the-board-of-directors2023-11-09T09:12:33Z https://sofinnovapartners.com/team/estelle-rigaux2025-07-03T10:21:44Z https://sofinnovapartners.com/news/cincor-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-brightn-data-on-selective-aldosterone-synthase-inhibitor-baxdrostat-in-treatment-resistant-hypertension2022-11-08T09:11:58Z https://sofinnovapartners.com/team/nicolas-tuvi2024-10-07T14:59:15Z https://sofinnovapartners.com/news/signature-of-a-partnership-agreement-with-kiro2024-03-18T18:14:29Z https://sofinnovapartners.com/news/asceneuron-expands-scientific-advisory-board-with-world-leading-experts-in-neurodegenerative-diseases2024-03-06T15:44:25Z https://sofinnovapartners.com/news/tenpoint-therapeutics-ltd-and-visus-therapeutics-inc-join-forces-building-the-next-era-of-best-and-first-in-class-ophthalmic-medicines2025-08-14T15:06:43Z https://sofinnovapartners.com/news/tissium-announces-clinical-results-of-coaptium-r-connect-system-for-atraumatic-sutureless-nerve-repair2025-08-13T15:08:39Z https://sofinnovapartners.com/news/first-u-s-patient-successfully-treated-with-pi-cardia-s-shortcut-tm2022-12-19T15:23:09Z https://sofinnovapartners.com/news/mablink-bioscience-announces-a-eur31-million-series-a-funding-round-led-by-sofinnova-partners-and-merieux-equity-partners2022-10-14T05:56:41Z https://sofinnovapartners.com/news/afyren-is-ramping-up-its-efforts-to-create-a-new-path-for-organic-waste-recovery2024-03-07T17:52:46Z https://sofinnovapartners.com/news/sofinnova-partners-welcomes-mano-iyer-as-venture-partner2023-02-15T10:21:26Z https://sofinnovapartners.com/news/muna-therapeutics-awarded-usd4-9m-grant-from-the-michael-j-fox-foundation-for-parkinson-s-research2022-10-11T08:59:04Z https://sofinnovapartners.com/news/sitryx-therapeutics-strengthens-leadership-team-with-appointment-of-ravi-m-rao-as-chief-medical-officer2022-04-12T13:00:06Z https://sofinnovapartners.com/news/pincell-announces-2-successful-in-vivo-studies-for-breakthrough-skin-disease-therapy2023-05-04T08:08:43Z https://sofinnovapartners.com/news/moon-surgical-expands-leadership-team-to-accelerate-commercial-growth-across-u-s-and-europe2025-08-12T13:58:33Z https://sofinnovapartners.com/portfolio/verona-pharma-plc2023-06-09T04:32:48Z https://sofinnovapartners.com/news/pi-cardia-successfully-completes-enrollment-in-pivotal-study-for-shortcut-tm2023-09-20T13:10:54Z https://sofinnovapartners.com/news/video-sofinnova-partners-2024-annual-general-meeting2024-08-02T09:11:49Z https://sofinnovapartners.com/news/astrazeneca-closes-acquisition-of-amolyt-pharma2025-08-26T08:52:56Z https://sofinnovapartners.com/news/safeheal-closes-eur40-million-financing-co-led-by-sofinnova-partners-and-genesis-medtech-to-finance-its-colovac-device-through-a-pivotal-clinical-trial-in-the-united-states2022-01-31T09:20:09Z https://sofinnovapartners.com/news/inventiva-announces-a-new-director-of-the-board-of-directors2022-11-22T09:52:29Z https://sofinnovapartners.com/team/elliott-puttock2024-09-27T19:12:01Z https://sofinnovapartners.com/team/enzo-petrelluzzi2024-08-05T15:25:28Z https://sofinnovapartners.com/news/sofinnova-publishes-2023-impact-report2024-04-09T15:12:25Z https://sofinnovapartners.com/news/brightheart-appoints-michael-butchko-as-chairman-of-the-board2025-08-27T05:49:10Z https://sofinnovapartners.com/team/monique-saulnier2025-12-16T22:18:25Z https://sofinnovapartners.com/team/paola-pozzi2025-12-16T22:15:02Z https://sofinnovapartners.com/team/kinam-hong2025-12-16T22:11:31Z https://sofinnovapartners.com/team/josko-bobanovic2026-02-02T10:07:33Z https://sofinnovapartners.com/team/michael-krel2025-12-16T22:12:49Z https://sofinnovapartners.com/team/ankeet-jethwa2026-02-02T10:30:31Z https://sofinnovapartners.com/team/tizian-rossetti2024-08-05T11:08:11Z https://sofinnovapartners.com/team/marion-gasperment2026-02-02T10:34:39Z https://sofinnovapartners.com/team/anta-ada-gkelou2025-12-16T22:10:32Z https://sofinnovapartners.com/team/bommy-lee2024-08-05T15:20:15Z https://sofinnovapartners.com/team/marc-lahoudie2024-08-05T15:18:34Z https://sofinnovapartners.com/team/nathalie-loreaux2024-08-05T15:21:03Z https://sofinnovapartners.com/news/industry-veteran-abbas-hussain-appointed-as-chair-of-asceneuron2023-12-18T10:09:12Z https://sofinnovapartners.com/news/latent-labs-announces-latent-x2-ai-generated-antibodies-with-drug-like-developability-and-low-ex-vivo-immunogenicity2025-12-16T09:51:50Z https://sofinnovapartners.com/news/sitryx-nominates-sit-047-a-novel-oral-mthfd2-inhibitor-for-clinical-development-in-psoriatic-arthritis2025-08-13T10:03:53Z https://sofinnovapartners.com/news/aavantgarde-bio-appoints-dr-natalia-misciattelli-as-chief-executive-officer2022-09-09T04:39:16Z https://sofinnovapartners.com/news/l-ecole-ai-creator-of-machine-teaching-technology-raises-3-million-usd-in-seed-funding-from-sofinnova-partners2023-10-26T04:01:07Z https://sofinnovapartners.com/news/Sofinnova MD Start III: Refining the model2023-10-20T17:13:53Z https://sofinnovapartners.com/news/catamaran-bio-to-present-preclinical-data-at-asgct-annual-meeting-to-support-car-nk-approach-for-solid-tumors2022-05-02T14:39:02Z https://sofinnovapartners.com/news/moon-surgical-receives-second-fda-clearance-covering-its-commercial-maestro-tm-surgical-robotics-system2025-08-27T06:00:15Z https://sofinnovapartners.com/news/invivo-partners-joins-sofinnova-partners-in-signadori-bio2025-04-07T07:27:18Z https://sofinnovapartners.com/strategy/crossover2025-12-12T18:09:49Z https://sofinnovapartners.com/news/Biotalys Announces Intention to Strategically Refocus its Activities to Prioritize Lead Assets and Reduce Annual Cash Burn2026-02-13T16:07:58Z https://sofinnovapartners.com/news/genespire-announces-that-gene202-has-been-granted-orphan-drug-designation-by-the-fda-and-ec-for-the-treatment-of-methylmalonic-acidemia2026-01-23T16:03:27Z https://sofinnovapartners.com/news/corwave-announces-second-closing-of-its-series-c-funding-at-eur61m-to-finance-its-first-industrial-deployment2024-08-06T13:34:36Z https://sofinnovapartners.com/news/reflexion-raises-usd80-million-to-broaden-cancer-treatment-options2022-03-11T07:09:48Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-boston-children-s-hospital-and-the-university-of-milan-reveal-use-of-novel-pathway-to-restore-pancreatic-cell-function-in-diabetes2022-02-07T06:59:25Z https://sofinnovapartners.com/portfolio/t-therapeutics2023-11-15T10:57:26Z https://sofinnovapartners.com/news/safeheal-r-closes-oversubscribed-eur35-million-series-c-equity-financing2025-08-13T14:44:58Z https://sofinnovapartners.com/portfolio/qorium2024-01-10T09:50:36Z https://sofinnovapartners.com/news/noema-pharma-announces-phase-2a-study-results-with-cendifensine-in-women-with-vasomotor-symptoms-hot-flashes-due-to-menopause2025-11-21T10:04:18Z https://sofinnovapartners.com/news/cincor-pharma-to-be-added-to-russell-2000-r-and-russell-3000-r-indexes2025-09-02T15:34:32Z https://sofinnovapartners.com/news/Enthera Pharmaceuticals Announces Publication in the Journal of Clinical Investigation Supporting the Clinical Development of Ebrasodebart2025-08-13T09:55:24Z https://sofinnovapartners.com/news/may-health-announces-data-from-feasibility-studies-of-its-novel-ovarian-rebalancing-tm-treatment-and-receives-approval-from-fda-for-pivotal-trial2023-06-26T10:03:43Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-appoints-aled-williams-as-chief-executive-officer2022-05-05T09:23:45Z https://sofinnovapartners.com/portfolio/disco-pharmaceuticals2024-08-06T11:09:29Z https://sofinnovapartners.com/news/rasmus-holm-jorgensen-appointed-cfo-at-aavantgarde2025-08-13T14:50:41Z https://sofinnovapartners.com/news/abivax-secures-up-to-eur-150m-from-two-structured-debt-financing-transactions2023-08-24T14:32:34Z https://sofinnovapartners.com/news/tenpoint-therapeutics-launches-with-usd70-million-series-a-financing-to-reverse-vision-loss-through-engineered-cell-based-therapeutics-and-in-vivo-reprogramming2023-07-12T10:45:03Z https://sofinnovapartners.com/news/statement-by-the-board-of-directors-of-calliditas-therapeutics-ab-publ-in-relation-to-the-public-offer-by-asahi-kasei-corporation2025-08-29T06:20:29Z https://sofinnovapartners.com/news/deepc and The AI Centre for Value-Based Healthcare enter partnership to accelerate and transform NHS adoption of radiology AI2025-08-22T15:38:39Z https://sofinnovapartners.com/news/inspirna-announces-interim-data-from-phase-1b-2-study-of-abequolixron-rgx-104-in-relapsed-or-refractory-lung-cancer2023-01-05T15:00:30Z https://sofinnovapartners.com/news/antoine-papiernik-discusses-theranos-in-lively-france-culture-podcast2022-03-03T11:35:15Z https://sofinnovapartners.com/news/pi-cardia-hires-gary-gratson-to-lead-global-commercialization2023-12-11T14:31:41Z https://sofinnovapartners.com/portfolio/betteromics2025-03-11T11:20:15Z https://sofinnovapartners.com/news/5-sofinnova-partners-portfolio-companies-selected-to-french-tech-1202022-02-02T08:12:14Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-initiates-phase-1-clinical-trial-with-lead-candidate-ent0012023-03-07T10:43:22Z https://sofinnovapartners.com/news/haya-therapeutics-raises-usd65-million-in-series-a-funding-to-deliver-precision-rna-guided-medicines-for-chronic-and-age-related-diseases2025-08-13T14:39:01Z https://sofinnovapartners.com/news/corwave-announces-the-grand-opening-of-its-manufacturing-facility-on-the-banks-of-the-seine-next-to-paris2024-08-06T13:27:14Z https://sofinnovapartners.com/news/bioptimus-unveils-m-optimus-a-world-model-for-biology2025-12-19T12:11:01Z https://sofinnovapartners.com/news/the-knowledge-project2025-08-14T14:58:53Z https://sofinnovapartners.com/news/maxcyte-signs-strategic-platform-license-with-catamaran-bio-to-support-its-car-nk-cell-therapy-programs2023-09-05T13:01:05Z https://sofinnovapartners.com/news/inotrem-announces-that-its-essential-phase-ii-study-for-the-treatment-of-critically-ill-covid-19-patients-meets-its-primary-and-key-secondary-endpoints2022-10-25T10:03:15Z https://sofinnovapartners.com/news/moon-surgical-announces-first-clinical-cases-in-the-u-s-using-maestro-system2023-09-26T11:10:30Z https://sofinnovapartners.com/news/sofinnova-partners-and-nvidia-collaborate-to-unleash-supercomputing-power-for-european-life-sciences-startups2025-08-12T14:21:13Z https://sofinnovapartners.com/news/DMC Biotechnologies Appoints Industry Veteran K’Lynne Johnson as Chair of the Board2025-08-12T12:43:39Z https://sofinnovapartners.com/news/mission-therapeutics-raises-gbp25-2-million-to-progress-clinical-candidates-in-the-area-of-mitophagy2024-03-19T09:41:31Z https://sofinnovapartners.com/portfolio/home-biosciences2022-01-03T11:31:25Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-two-new-partners-strengthening-team-of-next-generation-investors2024-04-22T20:07:09Z https://sofinnovapartners.com/news/qorium-bolsters-board-with-appointment-of-elizabeth-bastoni-and-martin-brok-renowned-experts-in-the-consumer-goods-and-retail-sectors2025-08-29T06:56:15Z https://sofinnovapartners.com/news/inventiva-announces-the-nomination-of-andre-turenne-as-director2025-08-29T08:02:22Z https://sofinnovapartners.com/news/noema-pharma-announces-fda-investigational-new-drug-authorization-for-phase-2b-study-of-trigeminal-neuralgia-therapy2022-02-15T07:10:58Z https://sofinnovapartners.com/news/biosyntia-raises-eur17-5-million-in-series-b-follow-on-to-advance-sustainable-production-of-active-ingredients2022-10-20T05:37:07Z https://sofinnovapartners.com/news/nanophoria-bioscience-publishes-groundbreaking-study-in-major-cardiology-journal2024-01-02T11:28:35Z https://sofinnovapartners.com/news/corriere-della-serra-interviews-graziano-seghezzi-after-sofinnova-partners-signs-deal-with-apollo2022-05-31T15:16:05Z https://sofinnovapartners.com/news/mediar-therapeutics-initiates-second-clinical-program-in-portfolio-of-novel-first-in-class-antibodies-designed-to-halt-fibrosis2025-08-25T17:09:40Z https://sofinnovapartners.com/news/abivax-reports-excellent-one-year-efficacy-and-safety-data-of-abx464-phase-2b-maintenance-trial-in-ulcerative-colitis2022-04-07T15:48:45Z https://sofinnovapartners.com/news/artios-pharma-strengthens-financial-leadership-with-appointment-of-christine-silverstein-as-chief-financial-officer2024-08-05T16:44:00Z https://sofinnovapartners.com/team/matthieu-dreno2024-10-07T15:05:06Z https://sofinnovapartners.com/news/Biotalys announces Closing of Private Placement2025-12-12T18:34:54Z https://sofinnovapartners.com/news/pyrowave-expands-its-microwave-technology-to-cement-decarbonization-in-partnership-with-the-university-of-sherbrooke-with-the-support-of-prima-quebec2024-08-08T17:04:11Z https://sofinnovapartners.com/news/Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism2025-08-29T07:11:05Z https://sofinnovapartners.com/team/alex-leech2025-12-16T22:13:08Z https://sofinnovapartners.com/news/asceneuron-joins-critical-path-for-alzheimer-s-disease-consortium2024-03-26T23:00:32Z https://sofinnovapartners.com/news/erydel-appoints-thomas-sabia-as-chief-commercial-officer2022-02-22T16:08:21Z https://sofinnovapartners.com/news/biotalys-starts-field-trials-for-second-biofungicide2025-08-29T07:12:50Z https://sofinnovapartners.com/news/the-keys-to-biotech-success-people-and-relationships2025-08-26T07:52:17Z https://sofinnovapartners.com/strategy/industrial-biotech2026-02-02T10:08:06Z https://sofinnovapartners.com/news/enginzyme-raises-eur21-million-in-series-b-to-accelerate-the-commercialisation-of-its-cell-free-biomanufacturing-technology2022-12-19T12:37:01Z https://sofinnovapartners.com/news/biotalys-receives-approval-for-large-scale-demonstration-trials-of-evoca-in-the-netherlands2025-12-12T18:35:06Z https://sofinnovapartners.com/portfolio/glycoera2022-01-03T11:31:25Z https://sofinnovapartners.com/news/inspirna-partners-with-merck-kgaa-darmstadt-germany-to-accelerate-global-development-of-ompenaclid-rgx-2022024-08-06T14:58:28Z https://sofinnovapartners.com/news/Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension2025-08-12T13:44:43Z https://sofinnovapartners.com/news/redx-nominates-gi-targeted-rock-inhibitor-rxc008-as-clinical-development-candidate2023-09-05T13:01:25Z https://sofinnovapartners.com/portfolio/julier-medical2023-01-23T09:02:53Z https://sofinnovapartners.com/news/moon-surgical-appoints-chris-toth-as-independent-board-member-ahead-of-commercial-acceleration2025-08-14T14:59:54Z https://sofinnovapartners.com/news/reflexion-expands-access-to-scintix-therapy-with-first-freestanding-cancer-center2025-08-14T14:08:26Z https://sofinnovapartners.com/news/sensorion-reports-six-month-update-from-the-audiogene-phase-1-2-trial-of-sens-501-and-advances-gjb2-gt-sens-601-toward-first-in-human-clinical-development2026-04-13T13:28:08Z https://sofinnovapartners.com/news/noema-pharma-announces-completion-of-enrollment-in-the-trigeminal-neuralgia-electronic-diary-tned-validation-study2022-09-07T10:17:42Z https://sofinnovapartners.com/portfolio/microphyt2023-03-27T09:11:37Z https://sofinnovapartners.com/news/calliditas-announces-positive-topline-results-of-phase-2-head-and-neck-cancer-trial-with-lead-nox-inhibitor-candidate-setanaxib2025-08-29T07:09:26Z https://sofinnovapartners.com/news/aavantgarde-appoints-nina-ekaterini-kotsopoulou-phd-as-chief-technical-officer2024-02-01T14:24:30Z https://sofinnovapartners.com/news/aavantgarde-announces-the-appointment-of-naveed-shams-m-d-ph-d-as-chief-development-and-medical-officer2022-06-30T10:40:11Z https://sofinnovapartners.com/news/sofinnova-partners-launches-biovelocita-the-first-pan-european-investment-strategy-dedicated-to-the-creation-and-acceleration-of-biotech-startups2024-02-05T18:23:29Z https://sofinnovapartners.com/news/sitryx-therapeutics-makes-key-appointments-to-strengthen-business-operations-and-progress-immunometabolism-targeting-pipeline-into-clinical-development2024-03-05T15:21:37Z https://sofinnovapartners.com/news/nephris-welcomes-discovery-of-novel-pathogenic-factor-in-diabetic-kidney-disease2022-08-10T19:08:14Z https://sofinnovapartners.com/news/CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production2025-08-13T15:07:16Z https://sofinnovapartners.com/news/nodthera-publishes-preclinical-data-demonstrating-reversal-of-obesity-and-inflammation-with-clinical-stage-brain-penetrant-nlrp3-inflammasome-inhibitors2024-02-27T10:02:05Z https://sofinnovapartners.com/news/sensorion-reports-new-positive-clinical-results-presented-at-the-world-congress-of-audiology2025-08-25T13:05:29Z https://sofinnovapartners.com/portfolio/meiogenix2022-01-03T11:31:25Z https://sofinnovapartners.com/news/elicit-plant-announces-eur45-million-investment-round-to-accelerate-global-expansion2025-08-22T15:28:02Z https://sofinnovapartners.com/news/biotalys-appoints-laura-j-meyer-to-board-of-directors2025-08-29T07:51:17Z https://sofinnovapartners.com/news/elicit-plant-breakthrough-first-european-registration-obtained-for-innovative-and-sustainable-agri-biotech-solution-mitigating-climate-change-impacts2024-08-08T16:01:45Z https://sofinnovapartners.com/news/aavantgarde-closes-usd141-million-series-b-financing2025-11-21T10:09:13Z https://sofinnovapartners.com/news/bioptimus-strengthens-commercial-and-scientific-leadership-with-key-hires2025-08-12T11:24:44Z https://sofinnovapartners.com/portfolio/bioptimus2024-02-21T13:49:13Z https://sofinnovapartners.com/portfolio/cellcentric2026-05-06T14:08:34Z https://sofinnovapartners.com/news/sofinnova-welcomes-agnes-pauquet-as-head-of-human-resources2025-08-25T12:51:21Z https://sofinnovapartners.com/news/afyren-raises-eur23-million-through-share-capital-increase-to-finance-optimization-and-expansion-of-unique-biorefinery-afyren-neoxy2025-11-26T06:54:50Z https://sofinnovapartners.com/news/redx-confirms-changes-to-board-composition2025-08-29T06:58:41Z https://sofinnovapartners.com/news/verley-becomes-first-company-to-receive-fda-no-questions-letter-for-functionalized-dairy-proteins-made-via-precision-fermentation2025-10-10T08:44:03Z https://sofinnovapartners.com/news/proqr-therapeutics-announces-usd8-1-million-in-new-funding-from-rett-syndrome-research-trust-to-expand-rna-editing-collaboration2025-08-14T15:02:02Z https://sofinnovapartners.com/news/cellcentric-announces-oversubscribed-usd220-million-series-d-financing-to-advance-pivotal-trials-of-inobrodib-in-multiple-myeloma2026-05-06T14:08:40Z https://sofinnovapartners.com/news/moon-surgical-receives-fda-clearance-for-scopilot-tm-on-maestro-industry-s-first-ai-enhanced-intraoperative-capability-powered-by-nvidia-holoscan2025-08-13T15:24:37Z https://sofinnovapartners.com/portfolio/mnemo-therapeutics2022-01-03T11:31:25Z https://sofinnovapartners.com/news/deepc-acquires-osimis-platform-strengthening-the-ai-infrastructure-for-radiology-at-scale2024-02-13T15:41:33Z https://sofinnovapartners.com/portfolio/abivax2022-01-03T11:31:25Z https://sofinnovapartners.com/news/noema-pharma-appoints-ilise-lombardo-m-d-as-chief-executive-officer2023-06-23T14:01:59Z https://sofinnovapartners.com/news/noema-pharma-appoints-michael-samar-as-chief-financial-officer2025-08-14T14:44:35Z https://sofinnovapartners.com/news/mainstay-medical-announces-exclusive-coverage-of-reactiv8-r-by-anthem-blue-cross-blue-shield2025-08-13T14:45:56Z https://sofinnovapartners.com/news/DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing2025-12-15T21:50:24Z https://sofinnovapartners.com/news/Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of immunomodulatory activity2026-01-28T08:50:52Z https://sofinnovapartners.com/portfolio/novameat2024-09-12T05:56:27Z https://sofinnovapartners.com/news/sofinnova-partners-raises-usd200m-digital-medicine-fund2024-02-06T06:34:15Z https://sofinnovapartners.com/news/redx-reports-encouraging-zamaporvint-rxc004-phase-2-combination-data-in-mss-mcrc-at-esmo-gi-congress-supporting-genetic-selection-hypothesis-in-hard-to-treat-gi-cancers2025-08-26T09:35:24Z https://sofinnovapartners.com/news/Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer2025-12-03T09:13:19Z https://sofinnovapartners.com/news/sofinnova-partners-announces-new-investment-in-nephris-an-innovative-biotech-targeting-chronic-kidney-diseases2022-04-20T07:12:49Z https://sofinnovapartners.com/news/corwave-announces-the-appointment-of-fairuz-hasni-as-vice-president-human-resources2024-08-06T13:25:24Z https://sofinnovapartners.com/news/noema-pharma-announces-recruitment-of-first-patient-in-orpheus-phase-2b-study-of-pde10a-inhibitor-gemlapodect-in-adults-with-childhood-onset-fluency-disorder2022-08-05T09:47:54Z https://sofinnovapartners.com/portfolio/nuage-therapeutics2023-06-20T10:20:52Z https://sofinnovapartners.com/news/mironid-extends-series-a-round-raising-gbp35-million-to-date-for-development-of-first-in-class-small-molecules-to-treat-life-threatening-hereditary-kidney-disease2023-09-13T08:33:38Z https://sofinnovapartners.com/news/biocortex-raises-usd5-million-in-funding-led-by-sofinnova-partners-and-hoxton-ventures-to-unlock-drug-bacteria-interactions2023-03-28T08:17:31Z https://sofinnovapartners.com/news/signadori-bio-raises-eur11-million-seed-round-to-advance-next-generation-solid-tumour-platform2026-05-06T07:06:40Z https://sofinnovapartners.com/regulatory-information2024-04-24T06:09:36Z https://sofinnovapartners.com/news/endoron-medical-awarded-a-eur2-5m-grant-from-the-european-commission-through-the-prestigious-eic-accelerator-program2023-10-20T17:12:07Z https://sofinnovapartners.com/news/Myricx Bio Announces Board Changes2025-08-26T09:21:14Z https://sofinnovapartners.com/portfolio/actithera2025-07-09T07:15:42Z https://sofinnovapartners.com/news/genespire-raises-eur46-6-million-usd52-million-in-a-series-b-round-to-advance-its-first-pediatric-in-vivo-gene-therapy-into-the-clinic2025-08-25T13:02:33Z https://sofinnovapartners.com/portfolio/cincor-pharma-inc2023-08-31T13:07:14Z https://sofinnovapartners.com/news/brightheart-secures-fda-clearance-for-first-ai-software-revolutionizing-prenatal-fetal-heart-ultrasound-evaluations2025-08-22T15:26:36Z https://sofinnovapartners.com/news/moon-surgical-s-first-in-human-trials-detailed-in-article2023-09-07T13:27:27Z https://sofinnovapartners.com/news/pixium-vision-announces-completion-of-implantations-in-the-european-pivotal-trial-primavera-and-confirms-target-read-out-around-the-end-of-2023-and-regulatory-submission-in-europe-in-h1-20242022-12-19T14:00:05Z https://sofinnovapartners.com/portfolio/forth-therapeutics2025-03-18T05:08:24Z https://sofinnovapartners.com/news/afyren-announces-the-industrial-commissioning-of-its-afyren-neoxy-plant-and-publishes-its-2021-full-year-results2022-03-25T10:22:53Z https://sofinnovapartners.com/news/tissium-appoints-sara-toyloy-as-independent-board-member2022-09-27T08:23:23Z https://sofinnovapartners.com/portfolio/Excelsior Sciences2025-12-09T10:47:05Z https://sofinnovapartners.com/news/mainstay-medical-announces-ususd125-million-equity-financing-transaction2026-04-09T13:34:21Z https://sofinnovapartners.com/news/mission-therapeutics-raises-usd13-3-million-to-progress-first-in-class-parkinson-s-disease-candidate-mtx325-through-clinical-trials2025-10-16T17:12:32Z https://sofinnovapartners.com/news/mainstay-medical-announces-exclusive-coverage-of-reactiv8-r-by-blue-cross-blue-shield2026-02-06T13:07:23Z https://sofinnovapartners.com/news/biotalys-and-novonesis-announce-manufacturing-and-commercialisation-partnership-for-evoca-ng2025-08-29T08:25:28Z https://sofinnovapartners.com/news/enginzyme-and-tetra-pak-join-forces-to-advance-sustainable-food-and-beverage-production2022-06-03T09:21:31Z https://sofinnovapartners.com/news/deepc-recognized-by-sofinnova-partners-as-a-top-performer-in-esg-excellence2025-11-28T19:40:54Z https://sofinnovapartners.com/news/noema-pharma-announces-first-patient-dosed-in-phase-2a-study-of-noe-115-a-first-in-class-investigational-therapy-for-the-treatment-of-vasomotor-symptoms-and-additional-symptoms-associated-with2025-08-29T06:46:17Z https://sofinnovapartners.com/news/aavantgarde-announces-first-patient-dosed-with-aavb-081-in-fih-phase-1-2-luce-1-study-for-retinitis-pigmentosa-related-to-ush1b2025-08-25T16:29:58Z https://sofinnovapartners.com/news/nuage-therapeutics-welcomes-olivier-corminboeuf-and-blandine-guimet-to-their-leadership-team2025-08-12T11:32:19Z https://sofinnovapartners.com/news/Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease2025-08-22T15:16:11Z https://sofinnovapartners.com/news/sensorion-announces-it-has-met-primary-endpoint-for-sens-401-phase-2a-clinical-study-for-residual-hearing-preservation2024-03-11T14:17:26Z https://sofinnovapartners.com/news/enhanced-data-security-and-quality-via-iso-27001-2022-and-soc-2-certifications-enables-moon-surgical-to-deliver-actionable-insights-to-healthcare-providers2025-08-22T15:41:16Z https://sofinnovapartners.com/news/aavantgarde-receives-fda-ind-clearance-to-progress-stargardt-disease-program-aavb-0392025-08-12T13:48:03Z https://sofinnovapartners.com/news/asceneuron-secures-usd100-million-series-c-financing-to-advance-groundbreaking-therapeutics-in-neurodegenerative-diseases2025-08-26T07:58:38Z https://sofinnovapartners.com/news/lilly-and-proqr-to-expand-rna-editing-collaboration2022-12-22T14:06:29Z https://sofinnovapartners.com/news/gensight-biologics-bolsters-regulatory-leadership-in-us-and-europe-with-two-senior-appointments2026-02-20T09:58:17Z https://sofinnovapartners.com/news/julier-medical-raises-eur3-million-in-seed-financing-from-sofinnova-partners-to-treat-patients-with-acute-ischemic-stroke2023-01-23T12:42:55Z https://sofinnovapartners.com/team/hadrien-pate2026-02-02T10:01:03Z https://sofinnovapartners.com/team/perrine-soupault2026-02-02T10:09:43Z https://sofinnovapartners.com/portfolio/arzeda2024-09-17T15:43:15Z https://sofinnovapartners.com/news/antoine-papiernik-and-sylvain-gariel-urge-france-to-invest-in-vaccines2022-09-14T15:00:27Z https://sofinnovapartners.com/news/gensight-biologics-appoints-william-monteith-to-its-board-of-directors2025-08-27T14:36:53Z https://sofinnovapartners.com/news/myricx-bio-announces-gbp90m-usd114m-series-a-financing-to-advance-its-novel-nmti-adc-therapeutics-into-clinical-development2025-08-26T09:28:33Z https://sofinnovapartners.com/news/adapt-or-go-extinct-novameat-unveils-the-ingredient-that-will-save-the-global-meat-crisis2026-04-13T14:19:04Z https://sofinnovapartners.com/news/highlife-receives-iso-13485-certification-of-its-quality-management-system2025-08-25T17:07:17Z https://sofinnovapartners.com/news/SafeHeal® Announces Successful Launch of SAFE-3CV IDE Study for Colovac® Anastomosis Protection Technology2026-01-13T18:02:25Z https://sofinnovapartners.com/news/first-patients-treated-with-tissium-s-atraumatic-hernia-repair-system2023-09-13T06:43:49Z https://sofinnovapartners.com/news/ex-google-deepmind-and-owkin-scientists-team-up-to-create-bioptimus-to-build-the-first-universal-ai-foundation-model-for-biology2024-02-21T13:39:54Z https://sofinnovapartners.com/news/baxdrostat-demonstrated-statistically-significant-and-clinically-meaningful-reduction-in-systolic-blood-pressure-in-patients-with-hard-to-control-hypertension-in-the-baxhtn-phase-iii-trial2025-09-03T11:08:02Z https://sofinnovapartners.com/news/Sitryx receives FDA clearance of IND application for SYX-5219 for the treatment of atopic dermatitis2025-10-03T11:23:06Z https://sofinnovapartners.com/news/moon-surgical-announces-ce-mark-for-its-commercial-maestro-system2023-09-19T10:16:33Z https://sofinnovapartners.com/strategy/telethon2025-12-12T18:19:07Z https://sofinnovapartners.com/news/biotalys-appoints-kamal-el-mernissi-as-chief-business-development-officer2025-12-12T18:35:30Z https://sofinnovapartners.com/news/les-echos-saving-french-biotech-Antoine Papiernik2022-02-04T08:02:37Z https://sofinnovapartners.com/news/aavantgarde-closes-eur61-million-series-a-financing-to-advance-two-therapeutic-programs-into-the-clinic2023-06-06T12:20:07Z https://sofinnovapartners.com/news/proqr-announces-top-line-results-from-phase-2-3-illuminate-trial-of-sepofarsen-in-cep290-mediated-lca102022-02-16T06:17:14Z https://sofinnovapartners.com/news/forth-tx-launches-with-backing-from-sofinnova-partners-to-revolutionize-fibrosis-treatments2025-08-13T15:37:46Z https://sofinnovapartners.com/news/bioptimus-appoints-julie-gerardi-as-chief-commercial-officer2025-08-12T13:49:12Z https://sofinnovapartners.com/news/cincor-pharma-appoints-marc-de-garidel-as-ceo2025-09-02T15:33:45Z https://sofinnovapartners.com/portfolio/cure-512024-08-20T08:41:45Z https://sofinnovapartners.com/news/artios-pharma-appoints-michael-t-andriole-as-ceo-and-director-to-advance-alnodesertib-art0380-into-late-stage-development2025-08-28T16:27:23Z https://sofinnovapartners.com/news/dr-neal-gutterson-joins-meiogenix-board2024-08-08T17:05:50Z https://sofinnovapartners.com/news/reflexion-announces-closing-of-usd125m-debt-facility-for-expanding-cancer-treatment2022-07-07T04:36:27Z https://sofinnovapartners.com/news/chroma-medicine-appoints-renowned-rna-scientist-melissa-moore-to-board-of-directors2025-08-26T07:54:41Z https://sofinnovapartners.com/news/nitrase-therapeutics-receives-new-grant-from-the-michael-j-fox-foundation-for-parkinson-s-research2022-04-06T07:20:38Z https://sofinnovapartners.com/news/highlife-launches-a-new-large-annulus-valve-in-ongoing-clinical-studies-for-patients-suffering-from-mitral-regurgitation2023-09-06T15:19:30Z https://sofinnovapartners.com/news/elicit-plant-appoints-pam-marrone-and-johan-de-saegher-to-its-board-of-directors2023-03-01T16:57:14Z https://sofinnovapartners.com/team/edward-kliphuis2026-02-02T10:17:13Z https://sofinnovapartners.com/news/tenpoint-therapeutics-ltd-announces-fda-acceptance-of-new-drug-application-for-brimochol-tm-pf-for-the-treatment-of-presbyopia2025-08-12T14:24:23Z https://sofinnovapartners.com/news/skidmore-owings-and-merrill-partners-with-prometheus-materials-to-design-zero-carbon-building-material2022-07-07T05:00:44Z https://sofinnovapartners.com/portfolio/nanophoria2024-08-08T13:49:56Z https://sofinnovapartners.com/team/aseem-ghaghda2025-04-15T14:09:46Z https://sofinnovapartners.com/news/highlife-appoints-prof-stephen-brecker-chief-medical-officer2024-02-22T07:32:46Z https://sofinnovapartners.com/news/strategic-partnership-for-sustainable-agriculture-bayer-and-elicit-plant-join-forces-in-france-for-maize-cultivation2025-08-26T07:46:57Z https://sofinnovapartners.com/news/welcome-to-our-new-website2022-01-06T16:02:38Z https://sofinnovapartners.com/portfolio/twentyeight-seven-therapeutics2023-06-09T04:32:27Z https://sofinnovapartners.com/portfolio/afyren2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/limflow2024-07-08T13:24:41Z https://sofinnovapartners.com/portfolio/corwave2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/inspirna-rgenix2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/corvidia-therapeutics-22022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/pixium2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/lysogene2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/synthace2025-10-09T10:21:06Z https://sofinnovapartners.com/portfolio/obseva2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/metgen2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/novexel2024-04-02T06:29:15Z https://sofinnovapartners.com/portfolio/ablynx-nv2024-04-02T06:32:45Z https://sofinnovapartners.com/portfolio/pyrowave2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/nchroma-formerly-chroma-medicine2025-01-09T14:10:07Z https://sofinnovapartners.com/portfolio/gradient-denervation-technologies2024-02-26T11:02:46Z https://sofinnovapartners.com/team/henrijette-richter2026-02-02T10:53:11Z https://sofinnovapartners.com/team/graziano-seghezzi2025-12-16T22:02:05Z https://sofinnovapartners.com/team/jacques-theurillat2025-04-17T14:37:08Z https://sofinnovapartners.com/team/anne-osdoit2026-02-02T10:32:23Z https://sofinnovapartners.com/team/cedric-moreau2025-12-16T22:13:43Z https://sofinnovapartners.com/team/guillaume-baxter2026-02-02T10:46:26Z https://sofinnovapartners.com/team/gerard-hascoet2023-10-26T04:40:19Z https://sofinnovapartners.com/team/silvan-spinelli2023-12-13T09:50:32Z https://sofinnovapartners.com/team/christophe-blanche2025-12-16T22:16:42Z https://sofinnovapartners.com/team/armance-bordes2025-12-16T22:17:03Z https://sofinnovapartners.com/team/stephanie-huiban2024-08-05T14:58:39Z https://sofinnovapartners.com/team/thomas-bermudes2026-02-02T10:36:46Z https://sofinnovapartners.com/team/johanna-guacide2023-09-05T17:27:26Z https://sofinnovapartners.com/team/sandrine-le-penru2023-09-05T17:28:39Z https://sofinnovapartners.com/team/paola-pizzi2024-08-05T15:25:53Z https://sofinnovapartners.com/team/claire-catherinet2026-02-02T10:48:29Z https://sofinnovapartners.com/team/gabriella-camboni2026-02-02T10:18:53Z https://sofinnovapartners.com/team/antoine-papiernik2025-12-16T22:02:33Z https://sofinnovapartners.com/team/lucia-faccio2025-12-16T22:10:06Z https://sofinnovapartners.com/team/maina-bhaman2025-12-16T22:07:11Z https://sofinnovapartners.com/team/cecile-dupont2025-12-16T22:09:43Z https://sofinnovapartners.com/team/zhizhong-yao2026-02-02T10:42:13Z https://sofinnovapartners.com/team/martin-t-rothman2023-09-05T17:29:18Z https://sofinnovapartners.com/team/bertrand-echalard2024-08-05T14:53:21Z https://sofinnovapartners.com/team/juliette-grant2023-09-06T08:18:54Z https://sofinnovapartners.com/team/lamia-verney2023-09-05T17:26:08Z https://sofinnovapartners.com/team/joseph-anderson2025-12-16T22:06:51Z https://sofinnovapartners.com/team/aziliz-le-roux2025-06-27T13:51:09Z https://sofinnovapartners.com/strategy/digital-medicine2025-12-12T18:21:44Z https://sofinnovapartners.com/portfolio/kiro2023-03-27T17:49:16Z https://sofinnovapartners.com/news/bioptimus-launches-h-optimus-0-the-world-s-largest-open-source-ai-foundation-model-for-pathology2025-08-26T09:18:30Z https://sofinnovapartners.com/news/moon-surgical-unlocks-the-intelligent-or-with-maestro-connectivity-and-insights-activation2025-12-19T12:14:18Z https://sofinnovapartners.com/news/Moon Surgical: Driving Robotics into High-Volume Surgery2022-01-06T16:02:39Z https://sofinnovapartners.com/news/proqr-appoints-peter-a-beal-phd-as-chief-adar-scientist2025-08-14T15:05:06Z https://sofinnovapartners.com/news/proqr-strengthens-leadership-with-appointments-of-cfo-and-cmo-to-support-next-phase-of-growth2025-08-13T14:59:45Z https://sofinnovapartners.com/news/nitrase-therapeutics-unveils-protein-with-newly-characterized-enzymatic-function-involved-in-the-pathogenesis-of-parkinson-s-disease2025-08-14T14:36:46Z https://sofinnovapartners.com/news/boehringer-ingelheim-licenses-novel-oral-therapeutics-program-for-immune-diseases-from-sitryx-therapeutics2026-02-27T17:25:04Z https://sofinnovapartners.com/news/gradient-denervation-technologies-announces-acceptance-into-fda-s-total-product-life-cycle-advisory-program-for-development-of-its-pulmonary-artery-denervation-system2025-08-12T14:09:32Z https://sofinnovapartners.com/news/cincor-pharma-announces-last-patient-randomized-in-phase-2-halo-trial-and-initiation-of-long-term-extension-study-for-baxdrostat-a-selective-aldosterone-synthase-inhibitor-in-uncontrolled-hypertension2022-07-27T13:15:51Z https://sofinnovapartners.com/team/alexandra-abreu2026-02-02T10:50:13Z https://sofinnovapartners.com/news/mission-therapeutics-awarded-usd5-2m-from-the-michael-j-fox-foundation-and-parkinson-s-uk-to-advance-potential-disease-modifying-treatment-mtx3252025-08-26T09:32:04Z https://sofinnovapartners.com/news/bioclec-launches-with-backing-from-sofinnova-partners-to-pioneer-breakthrough-alzheimer-s-therapies2025-08-13T15:35:37Z https://sofinnovapartners.com/news/abivax-reports-two-year-efficacy-and-safety-data-of-obefazimod-phase-2b-maintenance-trial-in-ulcerative-colitis2023-04-18T07:29:42Z https://sofinnovapartners.com/news/inventiva-and-sino-biopharm-announce-licensing-and-collaboration-agreement-to-develop-and-commercialize-lanifibranor-in-greater-china2022-09-23T05:05:46Z https://sofinnovapartners.com/news/In Memory of Denis Lucquin2026-04-14T07:23:47Z https://sofinnovapartners.com/news/gradient-denervation-technologies-closes-eur14m-series-a-led-by-sabadell-asabys2023-09-07T10:42:51Z https://sofinnovapartners.com/news/sofinnova-partners-enhances-leadership-in-medtech-acceleration-with-key-appointments2023-11-13T09:08:53Z https://sofinnovapartners.com/news/amid-the-buzz-at-jp-morgan-conference-sofinnova-partners-antoine-papiernik-is-optimistic2025-08-14T14:12:05Z https://sofinnovapartners.com/news/sofinnova-partners-brings-in-dr-joshua-makower-stanford-biodesign-co-founder-as-venture-partner2024-01-04T15:53:50Z https://sofinnovapartners.com/news/european-life-sciences-coalition-launched-to-strengthen-europe-s-life-sciences-investment-ecosystem2026-02-12T10:00:03Z https://sofinnovapartners.com/team/daniel-sieiro2024-08-05T11:11:48Z https://sofinnovapartners.com/team/karl-naegler2025-12-16T22:14:05Z https://sofinnovapartners.com/news/aavantgarde-appoints-michael-heffernan-as-chairman-of-its-board-of-directors2023-10-31T11:49:52Z https://sofinnovapartners.com/news/sensorion-announces-leadership-changes2026-04-13T13:42:34Z https://sofinnovapartners.com/news/pincell-s-studies-open-up-new-indications-for-lead-candidate2023-05-12T13:52:42Z https://sofinnovapartners.com/news/HighLife Receives CE Mark Approval for its TMVR Solution2026-01-26T06:44:23Z https://sofinnovapartners.com/team/pamela-putz2023-09-08T07:46:49Z https://sofinnovapartners.com/news/sitryx-announces-collaboration-partner-lilly-has-commenced-a-phase-1-study-of-sit-011-for-chronic-autoimmune-and-inflammatory-diseases2024-01-04T14:53:28Z https://sofinnovapartners.com/news/pi-cardia-receives-fda-market-clearance-for-shortcut-tm2025-08-25T12:58:49Z https://sofinnovapartners.com/news/MANE and Arzeda team up to offer next-gen sugar reduction solutions to the food and beverage industry2026-04-20T11:54:02Z https://sofinnovapartners.com/team/agnes-pauquet2024-10-15T07:00:13Z https://sofinnovapartners.com/features/2023-sofinnova-industrial-biotech-impact-report-a-hands-on-investment-strategy-driving-positive-change-for-the-planet2024-02-06T10:18:05Z https://sofinnovapartners.com/news/inari-medical-closes-acquisition-of-limflow2024-08-08T12:44:52Z https://sofinnovapartners.com/news/aavantgarde-bio-announces-fda-orphan-drug-designation-for-aavb-081-for-the-treatment-of-usher-syndrome-type-1b-retinitis-pigmentosa2025-08-22T15:22:00Z https://sofinnovapartners.com/news/sitryx-raises-additional-usd39-million-to-progress-development-of-disease-modifying-therapeutics-for-chronic-autoimmune-and-inflammatory-disease2023-09-27T15:11:21Z https://sofinnovapartners.com/news/sitryx-initiates-phase-1-clinical-trial-of-potential-disease-modifying-treatment-for-atopic-dermatitis-syx-52192025-08-13T15:20:53Z https://sofinnovapartners.com/news/nuage-therapeutics-raises-eur12m-in-seed-financing-led-by-sofinnova-partners-and-asabys2023-06-22T07:05:13Z https://sofinnovapartners.com/news/sofinnova-partners-unveils-sofinnova-ai-a-cutting-edge-artificial-intelligence-platform-set-to-transform-its-life-sciences-investment-practice2023-12-05T09:31:59Z https://sofinnovapartners.com/news/pyrowave-introduces-nanopurification-technology-a-revolutionary-short-loop-chemical-recycling-innovation-to-remove-toxic-additives-and-contaminants-in-plastics2024-08-08T17:01:49Z https://sofinnovapartners.com/news/novameat-raises-eur17-4m-oversubscribed-series-a-round-led-by-sofinnova-partners-and-forbion2025-08-25T16:32:43Z https://sofinnovapartners.com/news/qorium-lands-additional-funds-from-brightlands-venture-partners-and-sofinnova-partners-as-the-company-sets-out-on-an-ambitious-growth-drive-for-sustainable-leather-with-the-appointment-of-ceo-michael2024-01-10T11:31:22Z https://sofinnovapartners.com/news/abivax-reports-promising-abx464-phase-2a-one-year-maintenance-results-in-rheumatoid-arthritis2022-03-11T07:10:49Z https://sofinnovapartners.com/news/nanophoria-appoints-dr-suman-shirodkar-as-chair-and-prof-michael-davidson-as-non-executive-member-of-the-board-of-directors2024-01-08T10:20:33Z https://sofinnovapartners.com/news/sitryx-regains-rights-to-syx-1042-itaconate-mimetic-for-chronic-autoimmune-and-inflammatory-diseases-from-lilly-following-portfolio-reprioritization2025-08-12T11:20:45Z https://sofinnovapartners.com/news/brightheart-announces-eur2-million-in-seed-financing-from-sofinnova-partners-to-improve-the-detection-of-fetal-heart-abnormalities2023-05-31T08:19:42Z https://sofinnovapartners.com/news/pixium-vision-announces-fda-breakthrough-device-designation-for-the-prima-system-in-dry-amd2023-04-09T14:50:54Z https://sofinnovapartners.com/news/Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™2026-01-29T07:36:43Z https://sofinnovapartners.com/news/deepc-announces-distribution-agreement-with-hyland-software-to-enhance-medical-imaging-suite-with-cutting-edge-ai-technology2024-08-09T15:03:43Z https://sofinnovapartners.com/news/freya-biosciences-announces-usd38-million-funding-in-one-of-the-largest-series-a-raises-to-advance-women-s-reproductive-immunotherapies2023-12-28T20:05:26Z https://sofinnovapartners.com/news/purespring-therapeutics-granted-european-medicines-agency-ema-orphan-drug-designation-for-ps-002-for-the-treatment-of-patients-with-primary-iga-nephropathy-igan2025-08-13T14:49:29Z https://sofinnovapartners.com/news/prometheus-materials-raises-usd8-million-to-decarbonize-the-building-materials-industry-in-series-a-funding-round-led-by-sofinnova-partners2022-06-06T14:36:58Z https://sofinnovapartners.com/news/glycoera-ag-raises-usd130-million-to-advance-novel-pipeline-of-extracellular-protein-degraders-for-the-treatment-of-autoimmune-diseases2025-08-13T09:56:46Z https://sofinnovapartners.com/portfolio/may-health2024-01-29T15:23:53Z https://sofinnovapartners.com/news/pi-cardia-reports-first-commercial-cases-with-shortcut-tm2025-08-13T15:50:25Z https://sofinnovapartners.com/news/cure51-raises-a-eur15-million-seed-round-to-harness-the-natural-power-of-cancer-survivors-to-develop-first-in-class-treatments-and-transform-cancer-into-a-curable-disease2024-04-24T09:55:17Z https://sofinnovapartners.com/news/maestro-moon-surgical-s-rising-star2023-06-28T06:32:49Z https://sofinnovapartners.com/news/seghezzi-tells-unquote-that-after-apollo-deal-we-will-continue-to-build-on-our-strategy2022-05-31T14:13:58Z https://sofinnovapartners.com/news/cincor-pharma-announces-pricing-of-initial-public-offering2022-01-31T09:41:59Z https://sofinnovapartners.com/news/abivax-appoints-marc-de-garidel-as-chief-executive-officer-and-interim-board-chair2025-09-02T14:52:51Z https://sofinnovapartners.com/news/inspirna-appoints-dr-usman-oz-azam-m-d-as-new-chief-executive-officer2023-05-02T07:48:45Z https://sofinnovapartners.com/news/cincor-pharma-announces-topline-data-for-phase-2-halo-trial-evaluating-selective-aldosterone-synthase-inhibitor-baxdrostat-in-uncontrolled-hypertension2022-11-30T14:11:26Z https://sofinnovapartners.com/news/sofinnova-partners-raises-eur1-2-billion-to-fuel-the-next-wave-of-life-sciences-innovation2025-08-13T15:47:53Z https://sofinnovapartners.com/news/mnemo-therapeutics-names-robert-lacaze-as-ceo2022-02-23T09:03:54Z https://sofinnovapartners.com/news/calliditas-therapeutics-appoints-maria-toernsen-as-president-north-america2024-01-11T11:09:55Z https://sofinnovapartners.com/news/women-s-health-company-freya-biosciences-announces-key-usd10-4-million-strategic-investment2025-08-22T15:24:10Z https://sofinnovapartners.com/portfolio/tenpoint-therapeutics2023-07-12T10:40:16Z https://sofinnovapartners.com/news/bio-engineering-scale-up-qorium-showcases-cultivated-leather-breakthrough-signalling-a-key-step-towards-commercialisation2025-08-25T12:52:36Z https://sofinnovapartners.com/news/f2g-receives-complete-response-letter-from-fda-for-new-drug-application-for-olorofim-for-the-treatment-of-invasive-fungal-infections-plans-resubmission-with-additional-data-and-analyses2024-08-05T16:48:10Z https://sofinnovapartners.com/news/sensorion-announces-a-eur50-5-million-financing-with-participation-from-new-and-existing-us-and-european-healthcare-specialist-investors2024-02-09T09:12:13Z https://sofinnovapartners.com/news/inventiva-announces-the-positive-recommendation-of-the-third-dmc-of-the-phase-iii-clinical-trial-with-lanifibranor-in-patients-with-nash2023-12-07T10:31:53Z https://sofinnovapartners.com/portfolio/corvent-medical2022-01-03T11:31:25Z https://sofinnovapartners.com/news/safeheal-appoints-medical-device-industry-veteran-chris-richardson-as-chief-executive-officer2024-08-08T12:58:48Z https://sofinnovapartners.com/team/mariam-cherifi2024-08-05T10:35:46Z https://sofinnovapartners.com/news/Mainstay Medical Announces Positive Outcomes from Landmark RESTORE Clinical Trial of ReActiv8®2025-08-14T14:13:21Z https://sofinnovapartners.com/news/Excelsior Sciences Raises $95 Million to Transform Small Molecule Discovery and Manufacturing with Novel Chemistry that Machines Can Do2026-01-13T11:06:31Z https://sofinnovapartners.com/news/prof-jacques-seguin-renowned-inventor-of-corevalve-joins-endoron-medical-as-chairman-of-the-board2023-12-14T08:41:51Z https://sofinnovapartners.com/news/cincor-pharma-doses-first-patient-in-phase-2-fightn-ckd-trial-evaluating-the-selective-aldosterone-synthase-inhibitor-baxdrostat-cin-107-in-patients-with-uncontrolled-hypertension-and-chronic-kidney2022-06-01T15:16:53Z https://sofinnovapartners.com/news/artios-announces-oversubscribed-usd115-million-series-d-financing-to-accelerate-clinical-programs-in-indications-of-high-unmet-need2025-11-21T09:16:24Z https://sofinnovapartners.com/news/catamaran-bio-announces-appointment-of-michael-deridder-phd-as-senior-vice-president-corporate-strategy-and-new-product-planning2022-03-05T05:29:56Z https://sofinnovapartners.com/news/disco-pharmaceuticals-enters-license-agreement-to-advance-novel-cancer-surfaceome-targeted-therapies2026-01-07T10:33:21Z https://sofinnovapartners.com/news/sitryx-appoints-carrie-cook-as-chief-business-officer2023-08-22T09:35:16Z https://sofinnovapartners.com/news/Sofinnova Partners closes €650M ($750M) Capital XI, greatly exceeding initial target to back early-stage healthcare deals2025-11-21T10:14:10Z https://sofinnovapartners.com/news/abivax-announces-successful-oversubscribed-eur-130m-cross-over-financing-at-market-price-with-top-tier-us-and-european-biotech-investors2023-02-22T18:52:41Z https://sofinnovapartners.com/news/noema-pharma-founded-by-sofinnova-partners-raises-chf-103-million-usd112million-in-series-b-financing2023-03-09T10:21:20Z https://sofinnovapartners.com/team/antonin-weckel2024-09-27T19:29:49Z https://sofinnovapartners.com/news/tissium-strengthens-executive-leadership-team-with-key-appointments2025-08-14T14:05:57Z https://sofinnovapartners.com/news/Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support2025-08-13T15:39:07Z https://sofinnovapartners.com/news/gradient-denervation-technologies-appoints-stanton-rowe-to-board-of-directors-and-receives-fda-approval-to-expand-early-feasibility-study2025-08-25T12:42:23Z https://sofinnovapartners.com/news/cecile-dupont-md-start-partner-selected-as-in-vivo-rising-leader2023-08-29T13:41:06Z https://sofinnovapartners.com/news/nodthera-s-oral-nlrp3-inhibitor-nt-0796-enhances-and-sustains-weight-loss-in-combination-with-glp-12025-08-13T14:42:12Z https://sofinnovapartners.com/news/calliditas-therapeutics-announces-full-fda-approval-of-tarpeyo-r-the-only-fda-approved-treatment-for-iga-nephropathy-to-significantly-reduce-the-loss-of-kidney-function2023-12-21T15:17:45Z https://sofinnovapartners.com/news/henrijette-richter-discusses-r-and-d-in-plenary-at-wuxi-global-forum2022-01-31T08:44:51Z https://sofinnovapartners.com/news/moon-surgical-raises-usd31-3-million-to-accelerate-development-of-maestro-robotic-system2022-06-07T16:38:19Z https://sofinnovapartners.com/news/Meiogenix Hires Ricardo Garcia de Alba as CEO to Lead the Company through its Next Phase of Growth and Evolution to Serve a Broad Market and Customer Base2025-08-27T05:50:50Z https://sofinnovapartners.com/news/chroma-medicine-secures-usd135m-in-series-b-financing-to-advance-breakthrough-epigenetic-editing-technology-and-expand-pipeline-of-durable-precision-genomic-medicines2023-03-01T14:18:33Z https://sofinnovapartners.com/news/inventiva-announces-financing-of-up-to-eur348-million-to-advance-the-nativ3-phase-3-mash-study2025-08-25T12:54:12Z https://sofinnovapartners.com/news/catamaran-bio-announces-preclinical-data-from-allogeneic-car-nk-cell-therapy-pipeline-for-solid-tumors-to-be-presented-at-the-american-association-for-cancer-research-aacr-annual-meeting-20232023-04-14T17:39:00Z https://sofinnovapartners.com/news/recor-medical-and-otsuka-medical-devices-announce-first-fda-approved-renal-denervation-system-for-the-treatment-of-hypertension2023-11-08T10:55:36Z https://sofinnovapartners.com/news/pi-cardia-s-shortcut-tm-becomes-first-leaflet-modification-technology-to-receive-cms-ntap-for-valve-in-valve-tavr2025-08-12T11:27:35Z https://sofinnovapartners.com/portfolio/elicit-plant2022-08-01T14:20:09Z https://sofinnovapartners.com/news/mainstay-medical-announces-receipt-of-european-and-australian-approvals-of-mri-labeling-on-reactiv8-r-restorative-neurostimulation-system-tm2025-08-26T09:23:50Z https://sofinnovapartners.com/news/gfbiochemicals-raises-eur15m-series-a-to-advance-its-mission-to-end-chemical-pollution2022-05-05T14:54:20Z https://sofinnovapartners.com/news/afyren-chooses-thailand-for-its-second-biobased-organic-acids-plant-entering-a-partnership-project-with-mitr-phol-a-global-leader-in-the-sugar-industry2023-01-26T13:37:54Z https://sofinnovapartners.com/portfolio/endoron-medical2023-11-22T13:32:07Z https://sofinnovapartners.com/news/antoine-papiernik-tells-le-figaro-that-apollo-deal-will-help-sofinnova-finance-the-next-generation-of-game-changing-health-care-start-ups2022-05-31T14:07:40Z https://sofinnovapartners.com/news/t-therapeutics-appoints-dr-david-hung-as-chairman2025-08-27T05:53:42Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-karl-naegler-as-partner2025-08-25T16:36:06Z https://sofinnovapartners.com/news/catamaran-bio-appoints-cherry-thomas-md-as-chief-medical-officer2022-04-28T16:03:44Z https://sofinnovapartners.com/news/calliditas-initiates-clinical-study-to-evaluate-setanaxib-in-alport-syndrome2023-12-05T05:34:38Z https://sofinnovapartners.com/news/nodthera-announces-clinical-progress-for-lead-nlrp3-inflammasome-inhibitors-and-candidate-selection-of-novel-brain-penetrant-compound2022-05-10T13:46:23Z https://sofinnovapartners.com/news/safeheal-receives-breakthrough-device-designation-for-colovac-endoluminal-bypass-sheath2024-08-08T12:53:47Z https://sofinnovapartners.com/news/NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-07962025-08-12T13:35:36Z https://sofinnovapartners.com/news/tissium-raises-eur50m-in-series-d-funding-to-finance-its-commercial-launch-and-platform-extension2023-05-23T05:17:26Z https://sofinnovapartners.com/news/cincor-pharma-appoints-june-lee-to-its-board-of-directors2022-01-14T10:46:40Z https://sofinnovapartners.com/news/NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer2025-08-29T06:40:42Z https://sofinnovapartners.com/news/enginzyme-selected-for-cleantech-group-s-100-list-of-companies-committed-to-taking-action-on-the-climate-crisis2022-01-14T10:48:00Z https://sofinnovapartners.com/news/ashley-lakner-phd-joins-cure51-as-chief-scientific-officer-cso2026-02-06T13:16:46Z https://sofinnovapartners.com/portfolio/deepc2023-05-12T07:03:24Z https://sofinnovapartners.com/portfolio/biocortex2023-10-23T11:13:08Z https://sofinnovapartners.com/portfolio/l-ecole-ai2023-10-26T03:53:14Z https://sofinnovapartners.com/news/myricx-bio-further-strengthens-its-clinical-team-and-us-presence-with-the-appointment-of-david-ellis-as-vp-regulatory-affairs2025-09-19T14:49:20Z https://sofinnovapartners.com/news/safeheal-announces-successful-launch-of-pivotal-study-for-colovac-endoluminal-bypass-sheath2022-04-06T14:35:33Z https://sofinnovapartners.com/news/moon-surgical-s-maestro-system-powered-by-nvidia-holoscan-paves-the-way-to-next-generation-laparoscopy-with-over-200-patients-treated2025-08-29T08:22:27Z https://sofinnovapartners.com/news/henrijette-richter-discusses-apollo-deal-with-borsen-you-have-to-play-in-that-arena2022-05-31T14:10:05Z https://sofinnovapartners.com/news/cincor-s-marc-de-garidel-building-things-has-been-my-specialty2022-04-06T16:58:53Z https://sofinnovapartners.com/news/afyren-s-fermentation-lab-reaches-2-million-hour-mark-as-it-identifies-new-raw-materials-to-fuel-industrial-expansion2025-08-26T09:25:08Z https://sofinnovapartners.com/news/Noema Pharma Announces First Patients Dosed in Phase 2b Study with Gemlapodect (NOE-105), a First-In-Class Investigational Therapy for Tourette Syndrome2025-08-22T15:33:54Z https://sofinnovapartners.com/news/afyren-inaugurates-its-first-factory-afyren-neoxy-a-first-of-its-kind-biorefinery2022-09-29T06:01:39Z https://sofinnovapartners.com/news/inventiva-provides-an-update-on-its-nativ3-clinical-program-evaluating-lanifibranor-in-patients-with-mash-nash-and-its-financial-position2025-08-26T09:30:52Z https://sofinnovapartners.com/news/moon-surgical-receives-first-fda-510-k-clearance-for-its-maestro-tm-surgical-robotics-system2022-12-06T14:54:01Z https://sofinnovapartners.com/news/artios-pharma-bolsters-board-of-directors-with-appointment-of-chris-liu-phd2024-08-05T16:41:30Z https://sofinnovapartners.com/news/endoron-medical-raises-usd10-million-in-series-a-funding-led-by-sofinnova-partners-to-accelerate-the-validation-of-its-aaa-endostapling-solution-aortoseal2025-08-26T09:26:16Z https://sofinnovapartners.com/news/microphyt-raises-eur15-million-to-accelerate-the-commercialization-of-its-microalgae-based-natural-solutions-for-nutrition-and-well-being2022-11-30T14:09:46Z https://sofinnovapartners.com/news/micropep-ag-biotech-innovator-raises-eur8-75-million-from-global-syndicate-to-bring-ground-breaking-and-cost-effective-alternatives-to-conventional-crop-protection-products-to-market2024-04-02T06:33:00Z https://sofinnovapartners.com/news/sofinnova-partners-and-gustave-roussy-launch-first-biotech-company-through-strategic-partnership2025-08-13T15:41:12Z https://sofinnovapartners.com/news/cincor-pharma-announces-positive-topline-data-for-phase-2-brightn-trial-evaluating-baxdrostat-its-selective-aldosterone-synthase-inhibitor-in-treatment-resistant-hypertension2022-08-08T12:55:55Z https://sofinnovapartners.com/portfolio/nephris2022-04-20T06:37:45Z https://sofinnovapartners.com/news/Genespire appoints Karen Aiach-Pignet as Chief Executive Officer2025-08-25T16:34:06Z https://sofinnovapartners.com/news/amolyt-pharma-announces-usd138-million-series-c-financing-led-by-sofinnova-partners-and-co-led-by-intermediate-capital-group2023-01-06T18:28:11Z https://sofinnovapartners.com/news/inspirna-raises-usd50-million-in-series-d-financing2022-07-12T04:57:49Z https://sofinnovapartners.com/news/catamaran-bio-expands-collaboration-for-car-nk-cell-engineering-with-the-university-of-minnesota-and-secures-an-exclusive-patent-license-to-next-generation-manufacturing-technologies2022-03-14T15:48:00Z https://sofinnovapartners.com/news/hemab-therapeutics-announces-usd157-million-series-c-financing-to-advance-next-generation-treatments-for-underserved-bleeding-disorders2025-11-21T10:19:39Z https://sofinnovapartners.com/news/may-health-completes-treatment-of-five-participants-in-u-s-feasibility-study-of-its-ovarian-rebalancing-treatment-for-pcos-related-infertility2022-12-20T15:05:56Z https://sofinnovapartners.com/news/limflow-announces-agreement-to-be-acquired-by-inari-medical2024-08-08T12:45:09Z https://sofinnovapartners.com/features/Sofinnova-industrial-biotech-impact-report-20222024-02-02T10:22:21Z https://sofinnovapartners.com/portfolio/Purespring2024-10-09T11:15:03Z https://sofinnovapartners.com/news/one-biosciences-announces-eur15-million-series-a-financing-to-advance-clinical-single-cell-profiling2025-08-12T13:43:33Z https://sofinnovapartners.com/news/Biotalys Achieves First Milestone in Bioinsecticide Partnership with Syngenta2026-04-21T13:15:05Z https://sofinnovapartners.com/portfolio/latent-labs2025-02-13T08:02:23Z https://sofinnovapartners.com/portfolio/Galvanize2025-09-03T12:09:21Z https://sofinnovapartners.com/news/jazz-pharmaceuticals-enters-definitive-agreement-with-redx-pharma-to-acquire-global-rights-to-kras-inhibitor-program2024-02-08T08:31:44Z https://sofinnovapartners.com/news/latent-labs-and-aws-announce-collaboration-to-scale-generative-ai-for-the-life-sciences2025-08-13T10:05:02Z https://sofinnovapartners.com/news/nanophoria-bioscience-awarded-eur17-5-m-from-european-innovation-council-s-accelerator-program2025-08-14T14:03:27Z https://sofinnovapartners.com/news/dna-script-expands-leadership-team-with-appointment-of-madoo-varma-as-vice-president-of-business-development2024-08-08T16:20:42Z https://sofinnovapartners.com/news/mission-therapeutics-commences-landmark-trial-of-mtx325-a-potential-disease-modifying-treatment-for-parkinson-s-disease2025-08-29T08:17:32Z https://sofinnovapartners.com/news/sofinnova-partners-welcomes-andrew-m-weiss-as-venture-partner2023-12-21T16:58:19Z https://sofinnovapartners.com/news/mediar-therapeutics-doses-first-patient-in-phase-2-wisper-trial-of-mtx-463-for-idiopathic-pulmonary-fibrosis2025-08-12T14:19:14Z https://sofinnovapartners.com/news/abivax-provides-business-and-operational-update2023-09-08T11:34:52Z https://sofinnovapartners.com/news/gensight-biologics-announces-a-successful-offering-for-an-amount-over-eur9-2-million2024-05-07T07:31:38Z https://sofinnovapartners.com/news/NodThera Appoints Geoff McDonough, M.D., as Chief Executive Officer2026-02-06T13:10:13Z https://sofinnovapartners.com/news/fmc-corporation-and-micropep-technologies-announce-strategic-collaboration-to-co-develop-bioherbicide-solutions2024-04-02T06:33:17Z https://sofinnovapartners.com/features/impact-accountability-in-venture-capital-a-ready-reference-for-practitioners2025-01-09T13:18:01Z https://sofinnovapartners.com/news/bioptimus-announces-stela-the-world-s-largest-clinically-linked-spatial-biology-atlas-alongside-key-partners-10x-genomics-and-broad-clinical-labs2026-04-20T16:52:41Z https://sofinnovapartners.com/news/biontech-and-crescendo-biologics-announce-global-collaboration-to-develop-multi-specific-precision-immunotherapies2022-01-11T15:10:27Z https://sofinnovapartners.com/news/catamaran-bio-appoints-frank-lee-as-chair-of-its-board-of-directors2022-04-05T13:25:59Z https://sofinnovapartners.com/news/is-there-a-lack-of-european-late-stage-capital2022-02-01T06:06:10Z https://sofinnovapartners.com/news/exmoor-pharma-and-signadori-bio-launch-partnership-to-develop-next-generation-monocyte-based-cell-therapy-for-solid-tumours2025-06-17T10:18:47Z https://sofinnovapartners.com/news/brightheart-obtains-third-fda-clearance-and-pccp-approval-becoming-first-to-offer-one-integrated-solution-for-real-time-fetal-heart-documentation-and-chd-detection2025-08-13T10:07:37Z https://sofinnovapartners.com/news/may-health-raises-usd25-million-in-series-b-funding-to-advance-development-for-ovarian-rebalancing-therapy2025-08-29T07:03:43Z https://sofinnovapartners.com/news/BrightHeart Raises €11M Series A to Scale Expert-Level AI Platform for Prenatal Ultrasound2026-01-08T14:06:10Z https://sofinnovapartners.com/team/fourati-ahmed2024-08-05T14:57:53Z https://sofinnovapartners.com/news/sitryx-announces-partner-lilly-exercises-option-to-sit-011-for-chronic-autoimmune-and-inflammatory-diseases2023-11-01T08:56:02Z https://sofinnovapartners.com/news/proqr-announces-cta-submission-for-phase-1-study-of-ax-0810-targeting-ntcp2025-08-12T13:57:07Z https://sofinnovapartners.com/portfolio/freya-biosciences2023-12-12T13:54:06Z https://sofinnovapartners.com/portfolio/mediar-therapeutics2024-08-07T12:40:15Z https://sofinnovapartners.com/news/f2g-announces-data-from-phase-2b-study-at-id-week-2022-showing-positive-therapeutic-response-in-patients-with-invasive-fungal-infections-treated-with-olorofim2022-10-23T12:02:23Z https://sofinnovapartners.com/news/noema-pharma-appoints-michael-gutch-as-chief-financial-officer2022-03-01T05:29:09Z https://sofinnovapartners.com/news/elicit-plant-makes-c-and-en-s-list-of-10-start-ups-to-watch2023-11-21T06:43:54Z https://sofinnovapartners.com/news/mediar-therapeutics-enters-into-global-licensing-agreement-with-lilly-to-advance-first-in-class-wisp1-antibody-for-the-treatment-of-idiopathic-pulmonary-fibrosis-ipf2025-08-14T14:17:27Z https://sofinnovapartners.com/news/antoine-papiernik-speaks-at-growing-together-athens-event2022-05-04T07:16:43Z https://sofinnovapartners.com/news/moon-surgical-appoints-anne-renevot-as-chief-financial-officer2023-05-03T08:55:25Z https://sofinnovapartners.com/news/afyren-provides-business-update-on-its-afyren-neoxy-plant2025-08-27T14:31:08Z https://sofinnovapartners.com/news/simon-turner-talks-digital-medicine-at-lsi-usa-232023-07-07T05:36:27Z https://sofinnovapartners.com/news/sensorion-announces-new-positive-secondary-ecacy-endpoints-data-from-sens-401-phase-2a-clinical-trial-for-the-preservation-of-residual-hearing-loss2025-08-26T09:00:58Z https://sofinnovapartners.com/news/sitryx-nominates-syx-5219-a-novel-oral-and-targeted-pkm2-activator-for-clinical-development-in-atopic-dermatitis2024-04-10T09:23:30Z https://sofinnovapartners.com/news/actithera-raises-usd75-5m-in-oversubscribed-series-a-financing-to-redefine-precision-radioligand-therapy2025-08-12T13:54:03Z https://sofinnovapartners.com/news/arnault-tzanck-institute-in-nice-france-completes-inaugural-robotics-surgeries-with-moon-surgical-s-maestro-commercial-system2023-10-24T16:23:10Z https://sofinnovapartners.com/news/abivax-announces-completion-of-enrollment-for-the-phase-3-abtect-trials-in-patients-with-moderately-to-severely-active-ulcerative-colitis2025-08-13T14:43:44Z https://sofinnovapartners.com/news/sensorion-announces-a-eur15-million-financing-extending-cash-runway-until-the-end-of-20252024-04-08T09:42:57Z https://sofinnovapartners.com/news/prometheus-materials-secures-multiple-astm-certifications-bringing-initial-production-into-full-swing2023-02-08T06:24:33Z https://sofinnovapartners.com/portfolio/Signadori Bio2025-07-04T17:43:17Z https://sofinnovapartners.com/news/noema-pharma-announces-first-patient-dosed-in-phase-2b-libratn-study-of-mglur5-inhibitor-noe-101-in-trigeminal-neuralgia2022-02-22T16:34:25Z https://sofinnovapartners.com/news/Inventiva announces pricing of upsized public offering of approximately $150M American Depositary Shares2025-11-13T15:05:29Z https://sofinnovapartners.com/news/sensorion-announces-eur60-million-financing-with-a-eur20m-strategic-investment-from-sanofi-and-support-from-global-healthcare-specialists-to-advance-genetic-medicine-pipeline2026-01-28T07:06:01Z https://sofinnovapartners.com/news/elicit-plant-raises-eur16m-to-accelerate-r-and-d-and-marketing-of-its-natural-solution-for-reduction-of-crop-water-consumption2022-02-07T13:01:44Z https://sofinnovapartners.com/news/biotalys-and-agrofresh-partner-to-protect-fresh-produce2025-12-12T18:35:42Z https://sofinnovapartners.com/news/elicit-plant-announces-the-appointment-of-slavica-djonovic-ph-d-as-chief-scientific-officer-cso2024-08-08T16:04:40Z https://sofinnovapartners.com/team/martina-epi2026-02-02T10:12:20Z https://sofinnovapartners.com/news/avantium-and-carlsberg-sign-offtake-agreement-on-pef2024-04-02T06:33:30Z https://sofinnovapartners.com/news/aavantgarde-founder-and-chief-scientific-officer-professor-alberto-auricchio-is-elected-as-vice-president-of-the-european-society-of-gene-and-cell-therapy2022-12-21T14:13:13Z https://sofinnovapartners.com/news/introducing-latent-x-a-frontier-generative-ai-model-for-protein-binder-design-accessible-via-no-code-platform-for-push-button-protein-design2025-08-12T13:42:02Z https://sofinnovapartners.com/portfolio/haya-therapeutics2025-05-08T12:28:10Z https://sofinnovapartners.com/team/pauline-roca2025-07-07T14:56:02Z https://sofinnovapartners.com/news/Artios Strengthens Leadership Team to Accelerate Late-Stage Development of Potential First-in-Class Oncology Pipeline2026-04-13T13:41:44Z https://sofinnovapartners.com/news/world-s-first-cancer-patient-treated-with-reflexion-s-breakthrough-scintix-biology-guided-radiotherapy2023-08-23T14:55:52Z https://sofinnovapartners.com/news/recor-medical-and-otsuka-medical-devices-announce-primary-endpoint-met-in-the-radiance-ii-u-s-pivotal-trial-of-the-paradise-tm-system-for-the-treatment-of-hypertension2022-07-26T13:26:53Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-mats-eklund-as-partner-and-chief-operating-officer2022-11-10T18:27:35Z https://sofinnovapartners.com/news/aavantgarde-appoints-dr-doug-kerr-to-the-board-of-directors2023-09-12T08:24:36Z https://sofinnovapartners.com/news/brightheart-announces-voluson-tm-solution-store-collaboration-to-deliver-expert-level-ai-support-across-the-full-prenatal-ultrasound-exam2026-02-06T13:14:32Z https://sofinnovapartners.com/news/Tenpoint Therapeutics announces positive topline data from Phase 3 pivotal study, BRIO-II, of BRIMOCHOL™ PF for the treatment of presbyopia2025-08-14T14:19:35Z https://sofinnovapartners.com/news/pixium-vision-announces-successful-implantation-of-first-patient-in-the-netherlands-in-prima-system-european-pivotal-trial-primavera2022-07-27T12:28:05Z https://sofinnovapartners.com/news/sofinnova-partners-focus-on-people-and-science-at-the-core-of-investment-strategy2023-08-03T14:01:17Z https://sofinnovapartners.com/news/noema-pharma-receives-fda-fast-track-designation-for-basimglurant-noe-101-in-trigeminal-neuralgia2022-10-18T15:59:27Z https://sofinnovapartners.com/news/muna-therapeutics-announces-first-subjects-dosed-in-phase-1-trial-of-novel-oral-trem2-agonist-for-early-alzheimer-s-disease2025-11-21T10:12:38Z https://sofinnovapartners.com/news/inventiva-announces-positive-results-from-the-phase-ii-legend-proof-of-concept-study-combining-lanifibranor-with-empagliflozin-in-patients-with-mash-nash-and-t2d2024-08-02T17:31:55Z https://sofinnovapartners.com/news/chroma-medicine-announces-exclusive-license-agreement-with-the-whitehead-institute-for-novel-epigenetic-editing-technology2025-08-26T09:36:44Z https://sofinnovapartners.com/news/elevara-medicines-raises-usd70-million-series-a-to-advance-phase-2-rheumatoid-arthritis-trial-and-expand-pipeline2025-10-22T09:48:35Z https://sofinnovapartners.com/news/brightheart-unveils-breakthrough-ai-results-at-the-society-for-maternal-fetal-medicine-smfm-2025-pregnancy-meeting-revolutionizing-prenatal-care2025-08-14T14:10:15Z https://sofinnovapartners.com/portfolio/gensight-biologics2024-07-10T10:07:58Z https://sofinnovapartners.com/news/sofinnova-partners-charging-ahead-in-italy2022-02-09T07:30:15Z https://sofinnovapartners.com/news/enginzyme-produces-key-mrna-vaccine-ingredient-using-biocatalysis2023-10-25T11:40:21Z https://sofinnovapartners.com/news/myricx-pharma-announces-senior-team-expansion-with-appointment-of-cmo-and-heads-of-biology-and-bioinformatics2022-02-24T06:34:17Z https://sofinnovapartners.com/news/myricx-bio-announces-expansion-of-its-leadership-team-to-advance-nmti-adcs-into-clinical-development2025-08-13T15:04:38Z https://sofinnovapartners.com/news/sensorion-submits-clinical-trial-application-for-otof-gt-its-lead-gene-therapy-candidate-in-europe2023-07-20T07:01:36Z https://sofinnovapartners.com/news/Sensorion Announces the Appointment of Laurene Danon as Chief Financial Officer2024-07-01T10:33:58Z https://sofinnovapartners.com/news/abivax-announces-the-pricing-of-its-initial-public-offering-on-the-nasdaq-global-market2023-10-20T16:11:28Z https://sofinnovapartners.com/news/reflexion-receives-fda-clearance-for-scintix-biology-guided-radiotherapy-cutting-edge-treatment-applicable-for-early-and-late-stage-cancers2023-02-06T09:02:24Z https://sofinnovapartners.com/portfolio/advanced-perfusion-diagnostics2022-01-03T11:31:26Z https://sofinnovapartners.com/portfolio/aavantgarde-bio2022-01-03T11:31:26Z https://sofinnovapartners.com/news/syngenta-to-leverage-biotalys-agrobody-tm-technology-platform-to-expand-insecticide-biocontrol-pipeline2023-04-25T07:20:08Z https://sofinnovapartners.com/news/nodthera-demonstrates-reversal-of-neuroinflammation-and-inflammation-in-parkinson-s-disease-with-oral-nlrp3-inhibitor2025-08-28T16:31:32Z https://sofinnovapartners.com/news/inventiva-announces-that-its-ind-application-for-the-phase-ii-combination-trial-with-lanifibranor-and-empagliflozin-in-patients-with-nash-and-t2d-has-been-accepted-by-the-fda2022-03-08T09:16:22Z https://sofinnovapartners.com/news/inventiva-secures-a-new-patent-in-japan-expanding-the-ip-protection-of-its-lead-product-candidate-lanifibranor2025-08-26T07:43:38Z https://sofinnovapartners.com/news/f2g-announces-fda-filing-acceptance-of-new-drug-application-for-olorofim-for-the-treatment-of-invasive-fungal-infections2022-12-19T18:10:07Z https://sofinnovapartners.com/news/the-15-20-national-hospital-and-gensight-biologics-announce-the-treatment-of-the-first-patient-in-the-gs010-lumevoq-r-revise-study2026-02-20T09:58:29Z https://sofinnovapartners.com/news/amolyt-pharma-announces-phase-3-clinical-trial-of-eneboparatide-for-the-treatment-of-hypoparathyroidism-following-positive-end-of-phase-2-meeting-with-fda2023-05-02T14:48:16Z https://sofinnovapartners.com/news/myricx-bio-appoints-dr-chris-martin-biotech-entrepreneur-and-adc-pioneer-as-chairman-of-its-board-of-directors2023-11-15T19:50:38Z https://sofinnovapartners.com/news/acquisition-of-cincor-pharma-complete2023-02-27T08:29:44Z https://sofinnovapartners.com/news/sofinnova-s-henrijette-richter-talks-to-biocentury-about-creating-support-networks-for-first-time-ceos2022-09-05T12:36:16Z https://sofinnovapartners.com/news/genespire-appoints-dr-sabah-sallah-as-chief-medical-officer2022-07-07T11:02:01Z https://sofinnovapartners.com/news/sensorion-announces-positive-recommendation-from-the-data-safety-monitoring-board-dsmb-regarding-the-continuation-of-notoxis-its-phase-2a-clinical-trial-of-sens-401-in-cisplatin-induced-ototoxicity2025-08-26T07:45:15Z https://sofinnovapartners.com/news/bon-vivant-achieves-self-affirmed-gras-status-notifying-the-fda-of-its-recombinant-whey-protein-enabling-commercialization-in-the-u-s2025-08-14T14:42:08Z https://sofinnovapartners.com/news/mediar-therapeutics-announces-clinical-candidates-for-lead-fibrosis-programs-strategic-collaborations-and-key-leadership-addition2023-10-26T03:45:04Z https://sofinnovapartners.com/news/highlife-granted-us-fda-breakthrough-device-designation-for-its-tmvr-solution2025-08-13T15:02:59Z https://sofinnovapartners.com/news/brightheart-obtains-second-fda-clearance-for-expansion-of-platform-capabilities-adding-tablet-support-for-fetal-heart-ultrasound-evaluations2025-08-13T14:41:04Z https://sofinnovapartners.com/news/myricx-bio-enters-into-an-exclusive-antibody-license-agreement-with-wuxi-biologics2023-11-23T06:50:04Z https://sofinnovapartners.com/features/healthcare-in-the-post-covid-era-where-is-cell-and-gene-therapy-going2025-03-04T09:42:57Z https://sofinnovapartners.com/portfolio/sensorion2022-01-03T11:31:26Z https://sofinnovapartners.com/news/crescendo-biologics-announces-first-u-s-patients-dosed-in-expanded-phase-1b-clinical-trial-of-cb307-for-patients-with-mcrpc2024-08-06T13:15:16Z https://sofinnovapartners.com/news/alia-therapeutics-secures-eur4-4-million-seed-financing-extension-led-by-sofinnova-partners2023-04-17T14:55:39Z https://sofinnovapartners.com/news/Danone, DMC, Michelin and Crédit Agricole Centre France join forces to create a cutting-edge biotechnology platform2025-08-27T05:56:33Z https://sofinnovapartners.com/team/karine-smolovic2023-09-08T05:07:34Z https://sofinnovapartners.com/news/inventiva-draws-down-the-second-tranche-of-eur25-million-under-existing-finance-contract-with-the-european-investment-bank2024-08-02T09:44:42Z https://sofinnovapartners.com/news/tissium-announces-first-commercial-use-of-coaptium-r-connect-for-peripheral-nerve-repair-in-the-united-states2025-12-05T09:28:46Z https://sofinnovapartners.com/portfolio/pi-cardia2022-01-03T11:31:26Z https://sofinnovapartners.com/news/mission-therapeutics-granted-mhra-clinical-trial-authorisation-cta-for-mtx325-for-the-treatment-of-parkinson-s-disease2024-08-06T14:04:12Z https://sofinnovapartners.com/news/mablink-bioscience-enters-an-agreement-to-be-acquired-by-lilly2023-10-19T07:37:46Z https://sofinnovapartners.com/news/mainstay-medical-announces-publication-of-the-first-neuromodulation-study-for-low-back-pain-with-5-year-follow-up2025-08-29T08:24:19Z https://sofinnovapartners.com/portfolio/f2g2022-08-04T07:09:17Z https://sofinnovapartners.com/news/pi-cardia-receives-fda-ide-approval-for-pivotal-study-with-shortcut-tm-device2022-07-26T14:09:01Z https://sofinnovapartners.com/news/dmc-appoints-kelly-smith-as-vp-r-and-d2022-03-15T15:30:13Z https://sofinnovapartners.com/news/mironid-r-appoints-dr-catherine-kelleher-as-chief-medical-officer2024-08-06T14:50:51Z https://sofinnovapartners.com/news/sitryx-announces-leadership-transition2025-08-26T09:33:57Z https://sofinnovapartners.com/news/amolyt-pharma-announces-initiation-of-phase-1-clinical-trial-of-peptide-growth-hormone-receptor-antagonist-ghra-azp-3813-for-acromegaly2024-01-11T15:05:56Z https://sofinnovapartners.com/news/may-health-solidifies-veteran-executive-team-with-appointment-of-women-s-health-care-leader-anne-morrissey-as-ceo2022-09-09T13:26:38Z https://sofinnovapartners.com/news/inari-medical-expands-its-patient-focused-mission-with-agreement-to-acquire-limflow2023-11-02T05:54:20Z https://sofinnovapartners.com/news/f2g-moves-uk-headquarters-to-mediacity2024-08-05T16:50:22Z https://sofinnovapartners.com/news/moon-surgical-appoints-fred-moll-md-as-board-chair-and-raises-additional-usd55-4-million-in-new-funding-with-leading-investors-sofinnova-partners-and-nvidia2023-05-17T11:57:49Z https://sofinnovapartners.com/news/inventiva-announces-the-positive-recommendation-of-the-fourth-dmc-of-the-nativ3-phase-iii-clinical-trial-with-lanifibranor-in-patients-with-mash-nash2025-08-29T06:57:23Z https://sofinnovapartners.com/news/sensorion-announces-us-fda-grants-rare-pediatric-disease-designation-to-otof-gt-for-the-treatment-of-otoferlin-gene-mediated-hearing-loss2022-11-08T10:35:00Z https://sofinnovapartners.com/team/cristina-pelizon2025-04-15T14:10:39Z https://sofinnovapartners.com/news/sofinnova-partners-and-apollo-form-strategic-partnership-in-life-sciences2022-05-21T06:33:05Z https://sofinnovapartners.com/news/Qorium Secures €22m Investment to Accelerate Cultivated Leather Commercialisation2025-11-21T10:05:35Z https://sofinnovapartners.com/news/purespring-therapeutics-appoints-haseeb-ahmad-as-chief-executive-officer2025-08-13T15:43:02Z https://sofinnovapartners.com/news/gender-diversity-in-venture-capital-visible-and-invisible-barriers-slow-progress2023-11-09T14:01:55Z https://sofinnovapartners.com/news/biosyntia-closes-a-eur11-5-million-round-to-launch-world-s-first-bio-based-vitamin-b72022-07-08T05:32:07Z https://sofinnovapartners.com/portfolio/precardia2022-01-03T11:31:26Z https://sofinnovapartners.com/news/sitryx-appoints-adam-mostafa-as-chief-financial-officer2025-09-11T13:13:23Z https://sofinnovapartners.com/news/glycoera-ag-raises-chf-45-million-us-49-million-series-a-financing-to-develop-novel-biologics-based-on-innovative-glycoengineering-platform2022-01-06T16:02:46Z https://sofinnovapartners.com/news/sofinnova-partners-closes-63m-75m-oversubscribed-medtech-acceleration-fund2023-10-20T17:12:32Z https://sofinnovapartners.com/news/mainstay-medical-announces-reimbursement-approval-for-reactiv8-in-australia2022-03-15T13:03:19Z https://sofinnovapartners.com/news/shockwave-medical-announces-that-cms-has-created-new-codes-for-intravascular-lithotripsy2022-03-15T13:04:07Z https://sofinnovapartners.com/news/calliditas-therapeutics-prices-its-initial-public-offering-on-the-nasdaq-global-select-market-in-the-united-states2022-03-15T13:07:31Z https://sofinnovapartners.com/news/nodthera-announces-close-of-55-million-series-b-financing2022-03-15T13:09:14Z https://sofinnovapartners.com/news/rgenix-shows-clinical-activity-of-novel-agent-rgx-202-in-patients-with-kras-mutant-colorectal-cancer-in-phase-1-trial2022-03-15T13:11:11Z https://sofinnovapartners.com/news/reflexion-announces-clinical-collaboration-to-evaluate-biology-guided-radiotherapy-with-mercks-keytruda-for-certain-late-stage-cancers2022-03-15T13:14:57Z https://sofinnovapartners.com/news/biotalys-awarded-1.6-million-vlaio-research-grant2024-04-02T06:33:52Z https://sofinnovapartners.com/news/abivax-announces-german-regulatory-approval-of-abx464-covid-19-phase-2b/3-covid-19-clinical-trial2022-03-15T13:18:42Z https://sofinnovapartners.com/news/comet-bio-announces-positive-clinical-trial-results-for-its-prebiotic-arrabin2022-03-15T13:19:55Z https://sofinnovapartners.com/news/hotspot-therapeutics-completes-65-million-series-b-financing-to-advance-pipeline-of-novel-allosteric-medicines2022-03-15T13:20:54Z https://sofinnovapartners.com/news/muna-therapeutics-launches-with-us-73m-series-a-to-advance-novel-small-molecule-therapeutics-for-neurodegenerative-diseases2022-01-06T16:02:59Z https://sofinnovapartners.com/news/abivax-receives-ansm-and-ethics-committee-clearance-to-test-its-development-candidate-abx464-in-1034-covid-19-patients-in-randomized-phase-2b/3-clinical-trial2022-03-15T13:30:00Z https://sofinnovapartners.com/news/abx464-inhibits-replication-of-sars-cov-2-covid-19-in-reconstituted-human-respiratory-epithelium-model2022-03-15T13:33:47Z https://sofinnovapartners.com/news/genespire-and-sr-tiget-announce-strategic-alliance-for-the-development-of-transformative-gene-therapies-for-genetic-diseases-and-disclose-collaboration-focus2022-03-15T13:39:44Z https://sofinnovapartners.com/news/corvent-medical-a-coridea-portfolio-company-closes-4.5m-seed-financing-to-commercialize-the-first-single-use-critical-care-ventilator2022-03-15T13:40:58Z https://sofinnovapartners.com/news/pincell-appoints-veteran-biotech-and-biopharma-executives-to-management-team-and-board-of-directors2022-03-15T13:41:41Z https://sofinnovapartners.com/news/biotalys-first-biocontrol-proves-consistent-high-efficacy-in-global-fruit-and-vegetables-field-trial-program2024-04-02T06:34:23Z https://sofinnovapartners.com/news/verona-pharma-presents-expanded-analysis-of-ensifentrine-clinical-data-in-copd-maintenance-treatment-at-the-american-thoracic-society-2020-international-conference2023-08-24T16:05:00Z https://sofinnovapartners.com/news/pyrowave-closes-series-b-led-by-michelin-and-sofinnova-partners2022-03-15T14:53:15Z https://sofinnovapartners.com/news/genespire-secures-e16-million-series-a-financing-from-sofinnova-partners-to-advance-transformative-gene-therapies2022-03-15T14:53:43Z https://sofinnovapartners.com/news/enginzyme-secures-6.4-million-series-a-financing-round-led-by-sofinnova-partners2022-03-15T14:54:52Z https://sofinnovapartners.com/news/micropep-raises-eur-8.5m-usd-10m-in-oversubscribed-series-a-financing-to-develop-innovative-small-peptide-solutions-for-agriculture2024-04-02T06:34:07Z https://sofinnovapartners.com/news/nitrome-biosciences-raises-38m-series-a-financing-to-advance-therapeutics-targeting-a-novel-group-of-enzymes-involved-in-age-related-diseases2022-03-15T14:55:33Z https://sofinnovapartners.com/news/sofinnova-partners-announces-third-investment-from-its-italian-fund2022-03-15T14:57:02Z https://sofinnovapartners.com/news/pi-cardia-closes-a-27-million-financing-led-by-sofinnova-partners-to-continue-clinical-trials-with-its-leaflex-aortic-valve-technology2022-03-15T14:57:29Z https://sofinnovapartners.com/news/biotalys-establishes-scientific-advisory-board2024-04-02T06:35:33Z https://sofinnovapartners.com/news/reflexion-raises-100-million-for-cancer-treatment-commercialization2022-03-15T14:58:35Z https://sofinnovapartners.com/news/gensight-biologics-on-track-to-submit-lumevoq-for-european-approval-in-september-2020-following-pre-submission-meeting-with-ema2022-03-15T14:59:00Z https://sofinnovapartners.com/news/erydel-announces-completion-of-patient-enrollment-in-phase-3-attest-trial-the-largest-clinical-study-ever-conducted-in-ataxia-telangiectasia-at2022-03-15T14:59:27Z https://sofinnovapartners.com/news/shockwave-completes-enrollment-of-coronary-intravascular-lithotripsy-study-in-japan2022-03-15T15:00:10Z https://sofinnovapartners.com/news/calliditas-appoints-new-chief-medical-officer2022-03-15T15:01:21Z https://sofinnovapartners.com/news/reflexion-announces-first-sale-of-x1-machine-for-cancer-treatment2022-03-15T15:01:39Z https://sofinnovapartners.com/news/biotalys-announces-successful-54.6-million-initial-public-offering2024-04-02T06:35:06Z https://sofinnovapartners.com/news/shockwave-completes-enrollment-in-pivotal-study-for-coronary-intravascular-lithotripsy2022-03-15T15:02:57Z https://sofinnovapartners.com/news/tissium-receives-ce-mark-and-announces-manufacturing-compliance-certification-from-tuv-sud2022-03-15T15:04:40Z https://sofinnovapartners.com/news/calliditas-strengthens-its-us-commercial-organization2022-03-15T15:05:36Z https://sofinnovapartners.com/news/pixium-vision-announces-positive-follow-up-data-from-prima-system-study-in-dry-amd2022-03-15T15:06:28Z https://sofinnovapartners.com/news/proqr-announces-positive-findings-from-an-interim-analysis-in-the-phase-1-2-trial-of-qr-421a-for-usher-syndrome-and-provides-business-update2022-03-15T15:09:36Z https://sofinnovapartners.com/news/lilly-and-sitryx-announce-licensing-and-research-collaboration-to-discover-and-develop-new-immunometabolic-medicines2022-03-15T15:10:35Z https://sofinnovapartners.com/news/fda-clearance-brings-reflexion-closer-to-expanding-cancer-treatment-market2022-03-15T15:11:32Z https://sofinnovapartners.com/news/biotalys-announces-second-closing-of-e45-million-series-c-financing-round2024-04-02T06:36:05Z https://sofinnovapartners.com/news/bommy-lee-joins-sofinnova-partners-as-head-of-communications2022-03-15T15:14:36Z https://sofinnovapartners.com/news/sofinnova-partners-announces-three-new-investments-from-its-fund-dedicated-to-italian-scientific-research2022-01-06T16:03:37Z https://sofinnovapartners.com/news/biotalys-announces-collaboration-with-chrysal-to-evaluate-potential-of-biofungicide-in-flowers2024-04-02T06:36:39Z https://sofinnovapartners.com/news/sofinnova-partners-announces-the-promotion-of-michael-krel-to-partner-of-industrial-biotechnology-team2022-03-15T15:16:14Z https://sofinnovapartners.com/news/hookipas-gilead-sciences-collaboration-for-hiv-and-hbv-therapeutic-vaccines-advancing-towards-clinical-entry2022-03-15T15:17:54Z https://sofinnovapartners.com/news/medday-reports-last-patient-study-visit-in-phase-3-clinical-trial-with-md1003-an-important-step-towards-completion-of-the-spi2-study-in-progressive-multiple-sclerosis2022-03-15T15:19:17Z https://sofinnovapartners.com/news/inotrem-announces-enrollment-of-first-patient-in-its-phase-iib-astonish-trial-for-nangibotide-in-the-treatment-of-septic-shock2022-03-15T15:20:08Z https://sofinnovapartners.com/news/tissium-closes-e39m-series-b-funding-round2022-03-15T15:21:49Z https://sofinnovapartners.com/news/avantium-nominates-edwin-moses-as-chairman-of-its-supervisory-board2024-04-02T06:36:23Z https://sofinnovapartners.com/news/sofinnova-partners-raises-e333-million-capital-ix-early-stage-healthcare-fund2022-03-15T15:23:11Z https://sofinnovapartners.com/news/proqr-prices-50-million-underwritten-public-offering-of-ordinary-shares2022-03-15T15:23:40Z https://sofinnovapartners.com/news/iomx-therapeutics-strengthens-executive-management-team-and-supervisory-board-apollon-papadimitriou-ph-d-named-chief-executive-officer-marcus-irsfeld-appointed-as-chief-f2022-03-15T15:25:02Z https://sofinnovapartners.com/news/mnemo-therapeutics-announces-75-million-series-a-to-accelerate-next-generation-integrated-car-t-and-epigenetic-targeting-platform2022-01-06T16:03:49Z https://sofinnovapartners.com/news/micropep-technologies-strengthens-its-management-team-by-appointing-dr-mikael-courbot-as-chief-technical-officer2024-04-02T06:37:01Z https://sofinnovapartners.com/news/inotrem-announces-e39-million-series-b-financing-to-develop-first-in-class-immunology-therapeutics2022-03-15T15:26:18Z https://sofinnovapartners.com/news/hotspot-therapeutics-announces-acquisition-of-macroceutics-inc2022-03-15T15:26:54Z https://sofinnovapartners.com/news/sofinnova-partners-announces-the-sale-of-breath-therapeutics-to-zambon2022-03-15T12:52:26Z https://sofinnovapartners.com/news/comet-bio-completes-equity-financing-and-opens-u-s-headquarters-in-chicagoland-area2022-03-17T12:47:00Z https://sofinnovapartners.com/news/abivax-completes-e12-million-capital-raise-entirely-subscribed-by-sofinnova-partners-at-market-price2022-03-17T12:50:33Z https://sofinnovapartners.com/news/ablacare-announces-series-a-financing-of-e10-million-by-sofinnova-partners-for-innovative-infertility-treatment-and-appoints-jodie-fam-as-ceo-funds-to-support-european-fe2022-03-17T12:51:55Z https://sofinnovapartners.com/news/enginzyme-awarded-as-technology-pioneer-2021-by-world-economic-forum2022-01-06T16:04:01Z https://sofinnovapartners.com/news/dmc-biotechnologies-inc-announces-first-close-of-10-3m-series-a-financing-led-by-sofinnova-partners2022-03-17T12:53:27Z https://sofinnovapartners.com/news/comet-therapeutics-raises-28-5-million-series-a-financing-to-support-development-of-treatments-built-around-its-novel-coenzyme-a-platform2022-03-17T13:00:42Z https://sofinnovapartners.com/news/sofinnova-partners-dna-script-raises-38-5-million-in-series-b-financing2022-03-18T10:38:04Z https://sofinnovapartners.com/news/cincor-pharma-in-licenses-aldosterone-synthase-inhibitor-cin-107-and-closes-50-million-series-a-financing2022-03-17T13:02:18Z https://sofinnovapartners.com/news/sofinnova-partners-invests-in-twentyeight-seven-therapeutics-22022-03-17T13:04:08Z https://sofinnovapartners.com/news/hookipa-pharma-announces-pricing-of-initial-public-offering2022-03-17T13:05:08Z https://sofinnovapartners.com/news/nodthera-highlights-significant-progress-with-advancement-of-lead-development-candidate-and-key-additions-to-board-22022-03-17T13:05:41Z https://sofinnovapartners.com/news/safeheal-obtains-ce-mark-for-colovac-its-novel-endoluminal-bypass-sheath2022-03-17T13:06:39Z https://sofinnovapartners.com/news/afyren-and-the-spi-industrial-projects-fund-operated-by-bpifrance-announce-the-creation-of-an-industrial-company-afyren-neoxy2022-03-17T13:31:15Z https://sofinnovapartners.com/news/medtech-accelerator-sofinnova-md-start-iii-launches-a-call-for-early-stage-medical-device-projects2023-10-20T17:12:51Z https://sofinnovapartners.com/news/shockwave-announces-closing-of-its-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares-22022-03-17T13:41:30Z https://sofinnovapartners.com/news/dna-script-announces-worlds-first-enzymatic-synthesis-of-a-high-purity-200-nucleotide-strand-of-dna-22022-03-17T13:42:47Z https://sofinnovapartners.com/news/micropep-technologies-establishes-its-first-board-of-directors-and-appoints-kevin-p-smith-as-non-executive-chairman-22024-04-02T06:37:17Z https://sofinnovapartners.com/news/sofinnova-partners-antoine-papiernik-spoke-with-in-vivo-magazines-william-looney-on-european-venturecapital-investment-strategy-and-more-https-bit-ly-2gip9rz-invivonow-bi2022-03-17T13:44:06Z https://sofinnovapartners.com/news/hookipa-pharma-raises-37-4-million-e33-2-million-in-series-d-financing2022-03-17T13:45:19Z https://sofinnovapartners.com/news/our-managing-partner-and-chairman-antoine-papiernik-on-cnbc-giving-his-predictions-for-whats-next-in-biotech-https-cnb-cx-2vgrl3h-venturecapital2022-09-05T06:17:05Z https://sofinnovapartners.com/news/hookipa-appoints-michael-a-kelly-as-independent-director2022-03-17T13:48:25Z https://sofinnovapartners.com/news/afyren-secures-over-60-million-euros-of-financing-to-move-into-its-industrial-development-phase2022-03-17T13:51:04Z https://sofinnovapartners.com/news/inotrem-announces-an-extension-of-its-license-agreement-for-the-biomarker-soluble-trem-1-to-cardiovascular-diseases2022-03-17T13:51:48Z https://sofinnovapartners.com/news/avantium-takes-full-ownership-of-synvina2024-04-02T06:37:32Z https://sofinnovapartners.com/news/gensight-biologics-announces-nature-medicine-case-report-showing-visual-recovery-after-gs030-optogenetic-treatment2022-01-06T16:04:24Z https://sofinnovapartners.com/news/highlife-closes-a-e32-million-round-b-financing2022-03-17T13:53:10Z https://sofinnovapartners.com/news/asceneuron-appoints-peter-van-vlasselaer-as-chairman2022-03-17T13:53:42Z https://sofinnovapartners.com/news/pixium-vision-announces-its-wireless-prima-chip-successfully-met-the-interim-study-endpoints-for-dry-age-related-macular-degeneration2022-03-17T13:54:45Z https://sofinnovapartners.com/news/hookipa-achieves-first-research-milestone-in-hiv-collaboration-and-license-agreement-with-gilead2022-03-17T13:55:20Z https://sofinnovapartners.com/news/proqr-announces-publication-in-nature-medicine-of-qr-110-data-for-lebers-congenital-amaurosis-102022-03-17T13:55:58Z https://sofinnovapartners.com/news/shockwave-announces-collaboration-with-abiomed-on-physician-training2022-03-17T13:56:31Z https://sofinnovapartners.com/news/pixium-vision-awarded-galien-prize-2018-for-research-with-prima-system-for-dry-amd2022-03-17T13:57:09Z https://sofinnovapartners.com/news/computer-aided-biology-pioneer-synthace-secures-25-6-million-in-series-b-funding2023-09-05T13:02:02Z https://sofinnovapartners.com/news/hookipa-appoints-julie-oneill-as-a-non-executive-director2022-03-17T13:58:50Z https://sofinnovapartners.com/news/erydel-appoints-stan-musial-as-chief-financial-officer2022-03-17T13:59:39Z https://sofinnovapartners.com/news/abivax-reports-excellent-efficacy-and-safety-of-abx464-in-phase-2b-clinical-trial-in-ulcerative-colitis-and-plans-to-proceed-to-phase-32022-01-06T16:04:36Z https://sofinnovapartners.com/news/erydel-appoints-ronan-w-gannon-as-chief-commercial-officer2022-03-17T14:00:05Z https://sofinnovapartners.com/news/new-biopharmaceutical-company-sitryx-launches-with-30-million-fundraising-to-develop-disease-modifying-therapeutics-in-immunometabolism2022-03-17T14:03:22Z https://sofinnovapartners.com/news/synthace-launches-ground-breaking-new-whitepaper-computer-aided-biology-delivering-biotechnology-in-the-21st-century2023-09-05T13:02:23Z https://sofinnovapartners.com/news/dna-script-announces-worlds-first-enzymatic-synthesis-of-a-high-purity-150-nucleotide-strand-of-dna2022-03-17T14:21:02Z https://sofinnovapartners.com/news/inotrem-announces-positive-results-from-the-phase-iia-study-of-its-lead-compound-nangibotide-lr12-in-the-treatment-of-septic-shock2022-03-17T14:21:41Z https://sofinnovapartners.com/news/proqr-announces-closing-of-underwritten-public-offering-of-ordinary-shares-with-full-exercise-of-underwriters-option-to-purchase-additional-shares2022-03-17T14:22:13Z https://sofinnovapartners.com/news/hotspot-therapeutics-completes-45-million-series-a-financing-to-advance-new-approach-to-allosteric-drug-discovery2022-03-17T14:22:58Z https://sofinnovapartners.com/news/breath-therapeutics-appoints-noreen-roth-henig-m-d-as-chief-medical-officer2022-03-17T14:23:31Z https://sofinnovapartners.com/news/corwaves-next-generation-lvad-neptune-receives-funding2022-03-17T14:25:20Z https://sofinnovapartners.com/news/avantium-reaches-key-commercial-milestone-for-its-fdca-flagship-plant-with-commitments-for-50-of-its-output2024-04-02T06:37:45Z https://sofinnovapartners.com/news/sofinnova-partners-announces-the-sale-of-recor-medical-to-otsuka-holdings2022-03-17T14:26:12Z https://sofinnovapartners.com/news/renewable-chemicals-naturally-designed-and-engineered-to-deliver-the-performance-that-adds-value-to-everyday-products-32022-01-06T16:04:51Z https://sofinnovapartners.com/news/nodthera-secures-28-million-40-million-series-a-financing2022-03-17T14:27:53Z https://sofinnovapartners.com/news/hookipa-and-gilead-enter-into-a-collaboration-and-license-agreement-to-develop-immunotherapies-against-hiv-and-hepatitis-b2022-03-17T14:28:38Z https://sofinnovapartners.com/news/zai-lab-and-crescendo-biologics-enter-exclusive-worldwide-license-agreement-for-innovative-protein-therapeutics-for-inflammatory-indications2022-03-17T14:29:19Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-dr-martin-t-rothman-as-venture-partner2022-03-17T14:30:50Z https://sofinnovapartners.com/news/highlife-appoints-dr-martin-rothman-as-independent-mamber-of-the-board2022-03-17T14:31:51Z https://sofinnovapartners.com/news/shockwave-launches-coronary-intravascular-lithotripsy-in-europe2022-03-17T14:32:31Z https://sofinnovapartners.com/news/corvidia-therapeutics-secures-60-million-in-series-b-funding-to-accelerate-clinical-work2022-03-17T14:33:00Z https://sofinnovapartners.com/news/synthace-appoints-bob-wiederhold-as-chairman-of-its-board-of-directors2023-09-05T13:03:05Z https://sofinnovapartners.com/news/protera-appoints-novozymes-executive-thomas-videbaek-as-chair-of-the-board-of-directors-and-non-executive-board-member2022-01-06T16:05:01Z https://sofinnovapartners.com/news/sofinnova-partners-leads-erydels-e26-5-million-financing2022-03-17T14:34:38Z https://sofinnovapartners.com/news/armance-bordes-joins-sofinnova-partners-as-general-counsel2022-03-17T14:34:51Z https://sofinnovapartners.com/news/sofinnova-partners-leads-inventiva-pharma-e355-m-capital-increase2022-03-17T14:35:32Z https://sofinnovapartners.com/news/limflow-annonce-une-levee-de-fonds-serie-c-de-27-millions-deuros-mene-par-sofinnova-partners-pour-financer-son-programme-innovant-du-traitement-de-lischemie-critique-des-2022-03-17T14:36:41Z https://sofinnovapartners.com/news/enobraq-is-gaining-momentum2022-01-06T16:05:07Z https://sofinnovapartners.com/news/reflexion-medical-raises-100-million-series-c-to-commercialize-revolutionary-cancer-treatment2022-03-17T14:38:31Z https://sofinnovapartners.com/news/sofinnova-partners-launches-healthcare-crossover-fund-with-e275-million-340-million2022-03-17T14:39:27Z https://sofinnovapartners.com/news/sofinnova-partners-leads-safeheals-e6-million-series-a-financing-round2022-03-17T14:40:22Z https://sofinnovapartners.com/news/proqr-announces-positive-results-from-clinical-trial-of-qr-421a-in-usher-syndrome-and-plans-to-start-pivotal-trials2022-01-06T16:05:12Z https://sofinnovapartners.com/news/sofinnova-partners-leads-micropep-technologies-e4m-series-a-financing-round2024-04-02T06:39:05Z https://sofinnovapartners.com/news/gecko-biomedical-secures-e6-million-in-funding-under-the-investments-for-the-future-program-programme-dinvestissements-davenir-pia-to-industrialize-and-develop-innovative2022-03-17T14:43:59Z https://sofinnovapartners.com/news/pixium-vision-receives-fda-approval-to-begin-human-clinical-study-of-its-prima-retinal-implant-in-the-us2022-03-17T14:44:37Z https://sofinnovapartners.com/news/ecolab-agrees-to-acquire-minority-ownership-in-finnish-metgen-oy2022-03-17T14:45:29Z https://sofinnovapartners.com/news/mainstay-medical-announces-positive-outcome-of-interim-analysis2022-03-17T14:46:44Z https://sofinnovapartners.com/news/hookipa-biotech-raises-60-million-e50-million-in-an-oversubscribed-round-c-financing2022-03-17T14:47:03Z https://sofinnovapartners.com/news/highlife-appoints-jose-calle-gordo-as-chairman-of-the-board2022-03-17T14:47:51Z https://sofinnovapartners.com/news/avantium-secures-new-offtake-contracts-for-planned-fdca-flagship-plant2024-04-02T06:38:16Z https://sofinnovapartners.com/news/proqr-receives-orphan-drug-designation-from-ema-for-drug-candidate-qr-313-for-dystrophic-epidermolysis-bullosa2022-03-17T14:48:29Z https://sofinnovapartners.com/news/maina-bhaman-joins-sofinnova-partners-as-partner2022-03-17T14:49:02Z https://sofinnovapartners.com/news/inotrem-granted-access-to-priority-medicines-scheme-prime-for-its-lead-compound-motrem-in-the-treatment-of-septic-shock2022-03-17T14:50:48Z https://sofinnovapartners.com/news/proqr-doses-first-lca-10-patient-in-clinical-trial-of-qr-110-proqrs-lead-program-for-genetic-blindness2022-03-17T14:51:35Z https://sofinnovapartners.com/news/inotrem-and-roche-diagnostics-sign-a-rd-collaboration-agreement-in-the-field-of-septic-shock-to-develop-a-companion-diagnostic-test2022-03-17T14:52:26Z https://sofinnovapartners.com/news/highlife-closes-e12-3-million-financing-round-led-by-sofinnova-partners2022-03-17T14:53:04Z https://sofinnovapartners.com/news/inotrem-bolsters-leadership-team-with-the-appointment-of-sven-zimmermann-as-new-ceo2022-01-06T16:05:38Z https://sofinnovapartners.com/news/avantium-nominates-kees-verhaar-as-chairman-supervisory-board2024-04-02T06:38:29Z https://sofinnovapartners.com/news/pixium-vision-receives-approval-for-first-in-human-clinical-trial-of-prima-its-miniaturized-sub-retinal-implant2022-03-18T10:41:36Z https://sofinnovapartners.com/news/dr-jan-van-de-winkel-joins-hookipa-as-chairman-of-its-board-of-directors2022-03-18T10:41:59Z https://sofinnovapartners.com/news/shockwave-medical-announces-35-million-in-new-financing2022-03-18T10:42:34Z https://sofinnovapartners.com/news/nucana-plc-announces-pricing-of-initial-public-offering2022-03-18T10:45:05Z https://sofinnovapartners.com/news/p10217-15869589902632022-03-18T10:45:52Z https://sofinnovapartners.com/news/moon-surgical-and-kings-college-london-announce-strategic-partnership-to-develop-machine-learning-for-computer-assisted-surgery2022-01-06T16:05:50Z https://sofinnovapartners.com/news/synthace-raises-7-3m-to-accelerate-biotechnology-to-enable-faster-breakthroughs2023-09-05T13:03:38Z https://sofinnovapartners.com/news/proqr-receives-orphan-drug-designation-from-fda-for-drug-candidate-qr-313-for-dystrophic-epidermolysis-bullosa-and-will-present-data-at-two-scientific-conferences2022-03-18T10:48:12Z https://sofinnovapartners.com/news/sofinnova-partners-announces-dna-script-successful-series-a-fundraising-of-e11-m-to-advance-development-of-its-dna-synthesis-technology2022-03-18T10:48:58Z https://sofinnovapartners.com/news/proqr-rd-day-highlights-progress-on-pipeline-and-introduces-axiomer-a-novel-proprietary-rna-technology2022-03-18T10:50:23Z https://sofinnovapartners.com/news/calliditas-announces-submission-of-new-drug-application-to-u.s.-fda-for-nefecon-in-patients-with-primary-iga-nephropathy2022-01-06T16:06:02Z https://sofinnovapartners.com/news/avantium-n-v-proudly-announces-that-a-bbi-subsidy-of-eur-25-million-has-been-granted-to-the-industry-consortium-peference-the-consortium-consisting-of-11-companies-includ2024-04-02T06:38:44Z https://sofinnovapartners.com/news/proqr-to-present-qr-010-data-at-the-european-cystic-fibrosis-society-conference-and-provides-an-update-on-the-ongoing-phase-1b-trial2022-03-18T10:51:25Z https://sofinnovapartners.com/news/proqr-receives-fast-track-designation-from-the-fda-for-qr-110-for-lebers-congenital-amaurosis-type-102022-03-18T12:15:36Z https://sofinnovapartners.com/news/graziano-seghezzi-appointed-managing-partner-of-sofinnova-partners2022-03-18T12:15:59Z https://sofinnovapartners.com/news/proqr-announces-results-for-the-first-quarter-of-20172022-03-18T12:16:19Z https://sofinnovapartners.com/news/abivax-publishes-data-of-abx464-induction-and-long-term-maintenance-phase-2a-ulcerative-colitis-study-in-the-prestigious-journal-gastroenterology2022-01-06T16:06:13Z https://sofinnovapartners.com/news/shockwave-medical-appoints-doug-godshall-as-president-and-ceo2022-03-18T12:18:25Z https://sofinnovapartners.com/news/mainstay-medical-starts-commercialization-of-reactiv8-for-the-treatment-of-chronic-low-back-pain-in-ireland2022-03-18T12:19:51Z https://sofinnovapartners.com/news/reflexion-medical-appoints-industry-veteran-todd-powell-president-and-ceo2022-03-18T12:20:59Z https://sofinnovapartners.com/news/hookipa-biotech-presents-positive-data-from-phase-1-first-in-human-trial-of-vaccine-against-cytomegalovirus2022-03-18T12:21:32Z https://sofinnovapartners.com/news/sofinnova-partners-closes-445m-540m-oversubscribed-late-stage-healthcare-crossover-fund2023-09-05T13:03:57Z https://sofinnovapartners.com/news/mission-therapeutics-and-university-of-oxford-awarded-research-grant-from-the-michael-j-fox-foundation2022-03-18T12:24:14Z https://sofinnovapartners.com/news/crescendo-biologics-appoints-philip-bland-ward-as-chief-scientific-officer2022-03-18T12:24:57Z https://sofinnovapartners.com/news/antoine-papiernik-appointed-chairman-of-sofinnova-partners2022-03-18T12:25:13Z https://sofinnovapartners.com/news/proqr-appoints-david-m-rodman-md-as-chief-development-strategy-officer2022-03-18T12:25:41Z https://sofinnovapartners.com/news/sofinnova-partners-announces-the-successful-ipo-of-avantium-a-front-runner-in-renewable-chemistry-which-raises-e103-m-on-euronext2024-04-02T06:39:22Z https://sofinnovapartners.com/news/obseva-starts-phase-3-clinical-program-for-nolasiban-in-art2022-03-18T12:27:21Z https://sofinnovapartners.com/news/breath-therapeutics-raises-eur-43-5-million-in-series-a-financing2022-03-18T12:27:53Z https://sofinnovapartners.com/news/sofinnova-partners-invests-in-agrosavfe2024-04-02T06:40:24Z https://sofinnovapartners.com/news/mainstay-medical-announces-us108-million-equity-financing-transaction2022-08-24T10:46:08Z https://sofinnovapartners.com/news/dr-igor-matushansky-appointed-global-head-research-and-development-of-hookipa-biotech2022-03-18T12:28:53Z https://sofinnovapartners.com/news/sofinnova-partners-raises-e106-million-in-a-first-closing-of-its-industrial-biotech-fund2024-04-02T06:40:41Z https://sofinnovapartners.com/news/comet-biorefining-completes-equity-financing2022-03-18T12:30:42Z https://sofinnovapartners.com/news/lysogene-receives-orphan-drug-designation-from-ema-for-lys-gm101-for-treatment-of-gm1-gangliosidosis2022-03-18T12:32:29Z https://sofinnovapartners.com/news/michael-clayman-m-d-ceo-of-flexion-therapeutics-talk-about-the-need-for-new-treatment-options-for-osteoarthritis-oa-and-flexions-lead-investigational-product-candidate-zi2022-01-06T16:06:44Z https://sofinnovapartners.com/news/bioamber-ceo-steps-down-current-coo-fabrice-orecchioni-named-president2022-01-06T16:06:45Z https://sofinnovapartners.com/news/pixium-vision-receives-nub-innovation-reimbursement-status-1-for-150-electrode-irisii-bionic-system-in-germany2022-03-18T12:34:55Z https://sofinnovapartners.com/news/sofinnova-partners-congratulates-portfolio-company-dna-script-for-the-success-of-its-142m-165m-oversubscribed-series-c-fundraise2022-01-06T16:06:48Z https://sofinnovapartners.com/news/enginzyme-extends-series-a-to-11-million-to-advance-cell-free-chemical-production-platform-in-funding-round-led-by-swedens-industrifonden2022-01-06T16:06:49Z https://sofinnovapartners.com/news/lysogene-announces-its-successful-ipo-on-euronext-paris-with-nearly-e22-6-m-raised2022-03-18T12:38:00Z https://sofinnovapartners.com/news/mainstay-medical-starts-commercialization-of-reactiv8-for-the-treatment-of-chronic-low-back-pain2022-03-18T12:38:55Z https://sofinnovapartners.com/news/sofinnova-partners-announces-the-acquisition-of-delinia-by-celgene-corporation2022-03-18T12:43:24Z https://sofinnovapartners.com/news/obseva-sa-announces-pricing-of-initial-public-offering2022-03-18T12:44:16Z https://sofinnovapartners.com/news/dna-script-adds-dr-heiner-dreismann-former-ceo-of-roche-molecular-diagnostics-to-board-of-directors2022-03-18T12:44:55Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-extends-series-a-financing-raising-a-total-of-35m2024-10-16T09:19:55Z https://sofinnovapartners.com/news/cerenis-clinical-progress-cash-position-and-revenue-for-q4-20162022-01-06T16:07:03Z https://sofinnovapartners.com/news/obseva-expands-leadership-team-and-board-of-directors-with-industry-veterans2022-03-22T08:27:23Z https://sofinnovapartners.com/news/stentys-2016-annual-revenues-up-20-at-e7-3-million2022-01-06T16:07:05Z https://sofinnovapartners.com/news/pixium-vision-realise-limplantation-de-10-patients-avec-iris-ii-son-systeme-de-vision-bionique-innovant-a-150-electrodes-dans-le-cadre-de-son-etude-clinique2022-03-22T08:29:49Z https://sofinnovapartners.com/news/dna-script-to-present-at-the-biotech-showcase-conference-in-san-francisco2022-03-22T08:30:54Z https://sofinnovapartners.com/news/corwave-start-up-co-bfm-040120172022-03-22T08:31:49Z https://sofinnovapartners.com/news/biotalys-submits-first-protein-based-biocontrol-registration-package-to-the-epa2024-04-02T06:41:07Z https://sofinnovapartners.com/news/lysogene-appoints-david-schilansky-to-board-of-directors2022-01-06T16:07:17Z https://sofinnovapartners.com/news/asceneuron-appoints-j-michael-ryan-m-d-as-chief-medical-officer2022-03-22T08:40:52Z https://sofinnovapartners.com/news/shockwave-medical-raises-45-million-in-series-c-financing-to-further-advance-novel-lithoplasty-treatment-for-calcified-arteries2022-03-22T08:42:34Z https://sofinnovapartners.com/news/proqr-announces-results-for-the-third-quarter-of-20162022-03-22T08:44:16Z https://sofinnovapartners.com/news/moon-surgical-formerly-mastor-announces-appointment-of-experienced-core-team-to-accelerate-development2022-01-06T16:07:23Z https://sofinnovapartners.com/news/corwave-raises-17-1-million-in-series-b-financing2022-03-22T08:45:53Z https://sofinnovapartners.com/news/obseva-announces-results-of-the-implant-phase-2-trial-of-obe001-nolasiban-for-the-improvement-of-pregnancy-and-live-birth-rates-following-ivficsi2022-03-22T08:47:52Z https://sofinnovapartners.com/news/crescendo-biologics-and-takeda-enter-collaboration-for-humabody-based-therapeutics-worth-up-to-790m2022-03-22T08:49:15Z https://sofinnovapartners.com/news/asceneuron-receives-grant-from-the-michael-j-fox-foundation-for-parkinsons-research2022-03-22T08:50:08Z https://sofinnovapartners.com/news/iomx-therapeutics-raises-eur-40-million-in-series-a-round2022-03-22T08:54:03Z https://sofinnovapartners.com/news/corwave-raises-35-million-in-series-c-funding-for-its-breakthrough-heart-pump-eic-fund-joins-as-new-investor2022-01-06T16:07:34Z https://sofinnovapartners.com/news/delinia-announces-35-million-series-a-financing-to-advance-novel-therapeutics-targeting-regulatory-t-cells-for-autoimmune-diseases2022-03-22T08:55:04Z https://sofinnovapartners.com/news/rgenix-announces-33-million-series-b-financing-to-develop-first-in-class-cancer-therapeutics2022-03-22T08:56:56Z https://sofinnovapartners.com/news/jorn-aldag-appointed-ceo-of-hookipa-biotech2022-03-22T09:21:44Z https://sofinnovapartners.com/news/pixium-vision-receives-clinical-trial-approval-from-uk-regulatory-authority-for-150-electrode-irisii-bionic-vision-system2022-03-22T09:22:31Z https://sofinnovapartners.com/news/mainstay-medical-achieves-ce-marking-for-reactiv8-and-prepares-for-commercial-launch-in-germany2022-03-22T09:23:44Z https://sofinnovapartners.com/news/peijia-medical-and-highlife-enter-into-license-and-technology-transfer-agreement-for-transeptal-mitral-valve-replacement-in-greater-china2022-01-06T16:07:46Z https://sofinnovapartners.com/news/recor-medical-announces-collaboration-and-investment-with-otsuka-holdings-for-asian-commercialization-and-clinical-studies-in-the-us-and-europe2022-03-22T09:26:58Z https://sofinnovapartners.com/news/shockwave-medical-announces-positive-study-results-of-novel-lithoplasty-system-to-treat-peripheral-artery-disease-consistent-compelling-results-demonstrated-in-data-prese2022-03-22T09:27:44Z https://sofinnovapartners.com/news/proqr-announces-an-investor-and-analyst-event-and-pre-clinical-data-presentations-for-qr-110-for-lca10-at-the-2016-arvo-annual-meeting2022-03-22T09:32:21Z https://sofinnovapartners.com/news/medday-reports-full-data-from-pivotal-phase-iibiii-ms-spi-ms-on-studies-with-md1003-in-multiple-sclerosis-at-aan2022-01-06T16:07:50Z https://sofinnovapartners.com/news/avantium-raises-e20m-in-a-financing-round-led-by-pmv2024-04-02T06:41:27Z https://sofinnovapartners.com/news/3-new-funds-join-sofinnova-partners-in-enobraq-through-a-2-9-me-financing2022-01-06T16:07:53Z https://sofinnovapartners.com/news/reflexion-medical-raises-46-million-series-b-financing-led-by-kck-group2022-03-22T09:36:08Z https://sofinnovapartners.com/news/medday-secures-e34-million-38-5m-new-funding2022-01-06T16:07:56Z https://sofinnovapartners.com/news/corvent-medical-announces-strategic-partnership-with-siemens-healthineers-for-distribution-of-the-respond-19-ventilator2022-01-06T16:07:57Z https://sofinnovapartners.com/news/recor-medical-announces-initial-enrollments-in-the-radiance-htn-hypertension-clinical-trial2022-03-22T09:37:12Z https://sofinnovapartners.com/news/flexion-therapeutics-announces-presentation-of-results-from-pivotal-phase-2b-and-phase-3-clinical-trials-for-zilretta-at-osteoarthritis-research-society-international-oar2022-01-06T16:08:00Z https://sofinnovapartners.com/news/gecko-biomedical-raises-e22-5-million-led-by-sofinnova-partners2022-03-22T09:38:26Z https://sofinnovapartners.com/news/basf-and-avantium-intend-to-establish-joint-venture2024-04-02T06:42:16Z https://sofinnovapartners.com/news/cellucomp-completes-3-7-million-financing2022-03-22T09:40:06Z https://sofinnovapartners.com/news/world-premiere-pixium-vision-implants-iris-ii-first-epi-retinal-implant-with-150-electrodes2022-03-22T09:41:05Z https://sofinnovapartners.com/news/recor-medical-announces-ide-approval-for-radiance-htn-hypertension-clinical-trial2022-03-22T09:41:56Z https://sofinnovapartners.com/news/sonova-invests-5-million-in-sensorion-as-the-companies-plan-a-collaboration-in-hearing-loss2022-01-06T16:08:09Z https://sofinnovapartners.com/news/corvidia-therapeutics-raises-26m-in-a-series-a-financing-led-by-sofinnova-partners-and-apple-tree-partners2022-03-22T09:42:41Z https://sofinnovapartners.com/news/comet-biorefining-to-build-first-commercial-biomass-sugar-plant-in-sarnia-ontario2022-03-22T09:43:39Z https://sofinnovapartners.com/news/sofinnova-partners-leads-enyo-pharma-e22m-financing2022-03-22T09:44:18Z https://sofinnovapartners.com/news/mission-therapeutics-raises-60-million-to-progress2022-03-22T09:44:59Z https://sofinnovapartners.com/news/bioamber-inc-announces-pricing-of-13-0-million-public-offering2022-01-06T16:08:17Z https://sofinnovapartners.com/news/sofinnova-partners-raises-e300-million-healthcare-fund2022-03-22T09:47:24Z https://sofinnovapartners.com/news/gensight-biologics-announces-publication-of-results-from-lumevoq-reverse-pivotal-phase-iii-trial-and-non-human-primate-study-in-science-translational-medicine2022-01-06T16:08:21Z https://sofinnovapartners.com/news/additional-data-confirm-positive-results-for-clinical-trial-of-reactiv82022-03-22T12:35:03Z https://sofinnovapartners.com/news/twb-announces-the-creation-of-enobraq-specialist-in-co2-capture-and-exploitation-using-yeast-22022-01-06T16:08:23Z https://sofinnovapartners.com/news/lysogene-receives-orphan-drug-designation-and-rare-pediatric-disease-designation-from-the-fda2022-03-22T12:36:49Z https://sofinnovapartners.com/news/obseva-closes-chf-60-usd-60-million-in-series-b-financing2022-03-22T12:37:20Z https://sofinnovapartners.com/news/crescendo-biologics-appoints-dr-kevin-johnson-as-chairman2022-03-22T12:37:51Z https://sofinnovapartners.com/news/sofinnova-launches-biovelocita-the-first-biotech-accelerator-in-italy2022-01-06T16:08:28Z https://sofinnovapartners.com/news/twb-announces-the-creation-of-enobraq-specialist-in-co2-capture-and-exploitation-using-yeast2022-01-06T16:08:29Z https://sofinnovapartners.com/news/mainstay-medical-applies-for-ce-mark-for-reactiv8-22022-03-22T12:40:10Z https://sofinnovapartners.com/news/mainstay-medical-applies-for-ce-mark-for-reactiv82022-03-22T12:40:59Z https://sofinnovapartners.com/news/green-chemistry-on-an-industrial-scale-afyren-starts-construction-of-its-first-factory2022-01-06T16:08:32Z https://sofinnovapartners.com/news/reflexion-medical-achieves-major-milestones-in-development-of-biologically-guided-radiotherapy2022-03-22T12:41:33Z https://sofinnovapartners.com/news/dow-agrosciences-synthace-research-collaboration-to-accelerate-product-development-using-high-tech-tools2024-07-01T10:42:48Z https://sofinnovapartners.com/news/asceneuron-raises-chf-30-million-in-a-series-a-financing-round-led-by-sofinnova-partners2022-03-22T12:43:09Z https://sofinnovapartners.com/news/obseva-appoints-elke-bestel-as-chief-medical-officer-and-jean-pierre-gotteland-as-chief-scientific-officer2022-03-22T12:43:48Z https://sofinnovapartners.com/news/positive-results-for-mainstay-medicals-clinical-trial-of-reactiv82022-03-22T12:46:52Z https://sofinnovapartners.com/news/bio-world-congress-on-industrial-biotechnology2022-03-22T12:49:54Z https://sofinnovapartners.com/news/mozart-therapeutics-launches-with-55-million-series-a-financing-to-develop-disease-modifying-therapeutics-for-autoimmune-and-inflammatory-diseases2022-01-06T16:08:44Z https://sofinnovapartners.com/news/corvent-medical-receives-fda-emergency-use-authorization-of-its-novel-respond-19-ventilator-for-multiple-patient-use2022-01-06T16:08:45Z https://sofinnovapartners.com/news/internationally-renowned-medicinal-chemist-professor-chris-mcguigan-appointed-as-nucanas-chief-scientific-officer2022-03-22T12:50:36Z https://sofinnovapartners.com/news/mission-therapeutics-appoints-dr-colin-goddard-to-its-board-of-directors2022-03-22T12:51:10Z https://sofinnovapartners.com/news/nucana-appoints-martin-j-birkhofer-m-d-as-chief-medical-officer2022-03-22T12:51:39Z https://sofinnovapartners.com/news/mainstay-medical-strengthens-board-with-new-independent-director2022-03-22T12:52:51Z https://sofinnovapartners.com/news/creabilis-appoints-catherine-moukheibir-as-chairman-of-its-board-of-directors2022-01-06T16:08:56Z https://sofinnovapartners.com/news/hookipa-pharmas-lcmv-based-immunotherapy-for-hpv16-cancers-demonstrates-high-immunogenicity-according-to-peer-reviewed-article2022-01-06T16:08:57Z https://sofinnovapartners.com/news/mainstay-medical-gains-approval-to-start-us-clinical-trial-of-reactiv82022-03-22T12:56:13Z https://sofinnovapartners.com/news/shockwave-medical-announces-40-million-in-funding-for-novel-lithoplasty-system-to-treat-advanced-peripheral-coronary-vascular-and-aortic-valve-disease2022-03-22T12:57:47Z https://sofinnovapartners.com/news/stentys-next-generation-of-self-apposing-stent-system-receives-ce-marking-ahead-of-plan-22022-01-06T16:09:03Z https://sofinnovapartners.com/news/pixium-vision-announces-the-publication-of-prima-results-a-wireless-subretinal-implant-in-nature-medicine2022-03-22T13:00:36Z https://sofinnovapartners.com/news/medday-reports-positive-pivotal-phase-iii-study-results-with-md1003-in-patients-with-progressive-multiple-sclerosis2022-01-06T16:09:07Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-appoints-kazumi-shiosaki-to-its-board-of-directors-and-lisa-olson-to-its-scientific-advisory-board-to-push-forward-company-growth-and-development2022-01-06T16:09:08Z https://sofinnovapartners.com/news/medday-announces-its-pivotal-phase-iii-study-of-md1003-in-patients-with-progressive-multiple-sclerosis-meets-primary-endpoint2022-01-06T16:09:11Z https://sofinnovapartners.com/news/lysogene-appoints-annette-clancy-as-chair-of-the-board2022-03-22T13:03:15Z https://sofinnovapartners.com/news/cellucomp-plant-opened-by-annabelle-ewing-msp2022-03-22T13:03:50Z https://sofinnovapartners.com/news/redx-pharma-plc-placing-to-raise-c.25.5-million-and-open-offer-to-raise-up-to-2.2-million-and-conversion-of-loan-notes2023-09-05T13:04:19Z https://sofinnovapartners.com/news/proqr-therapeutics-announces-results-for-the-fourth-quarter-and-full-year-20142022-03-22T13:06:38Z https://sofinnovapartners.com/news/lysogene-university-of-massachusetts-medical-school-and-auburn-unniversity-announce-collaboration-agreement2022-03-22T13:07:33Z https://sofinnovapartners.com/news/comet-biorefining-secures-funding-led-by-sofinnova-partners-22022-03-22T13:09:01Z https://sofinnovapartners.com/news/sofinnova-partners-portfolio-company-glycovaxyn-sold-to-glaxosmithkline-for-212-m-in-an-all-cash-deal2022-03-22T13:10:04Z https://sofinnovapartners.com/news/ascendis-pharma-as-announces-closing-of-initial-public-offering-including-full-exercise-of-underwriters-option-to-purchase-additional-shares-22022-03-22T13:11:08Z https://sofinnovapartners.com/news/ascendis-pharma-as-announces-closing-of-initial-public-offering-including-full-exercise-of-underwriters-option-to-purchase-additional-shares2022-03-22T13:11:27Z https://sofinnovapartners.com/news/noema-pharma-raises-chf54-million-in-series-a-financing-round-led-by-sofinnova-partners-and-polaris-partners2022-01-06T16:09:31Z https://sofinnovapartners.com/news/promising-phase-i-interim-data-for-expec-vaccine-program-triggers-first-milestone-payment-in-clinical-co-development-with-janssen2022-01-06T16:09:32Z https://sofinnovapartners.com/news/promising-phase-i-interim-data-for-expec-vaccine-program-triggers-first-milestone-payment-in-clinical-co-development-with-janssen-22022-01-06T16:09:34Z https://sofinnovapartners.com/news/ascendis-pharma-as-announces-initiation-of-a-phase-1-single-ascending-dose-study-of-transcon-treprostinil-22022-03-22T13:14:31Z https://sofinnovapartners.com/news/ascendis-pharma-as-announces-initiation-of-a-phase-1-single-ascending-dose-study-of-transcon-treprostinil2022-03-22T13:14:54Z https://sofinnovapartners.com/news/mission-appoints-anker-lundemose-as-chief-executive-officer2022-03-22T13:15:48Z https://sofinnovapartners.com/news/shockwave-medical-announces-ce-mark-approval-of-its-lithoplasty-system-for-the-treatment-of-peripheral-artery-disease2022-03-22T13:16:22Z https://sofinnovapartners.com/news/home-biosciences-closes-usd15-million-seed-financing-led-by-redmile-group-and-sofinnova-partners2022-01-06T16:09:39Z https://sofinnovapartners.com/news/synthace-raises-usd35m-to-expand-access-to-its-revolutionary-r-and-d-technology-for-life-changing-research2023-09-05T13:00:10Z https://sofinnovapartners.com/news/sofinnova-partners-raises-eur150m-for-its-third-industrial-biotech-fund-dedicated-to-environmental-impact2024-04-02T06:42:52Z https://sofinnovapartners.com/news/catamaran-bio-launches-with-42-million-financing-to-develop-off-the-shelf-car-nk-cell-therapies-to-treat-solid-tumors2022-01-06T16:09:42Z https://sofinnovapartners.com/news/epsilen-bio-announces-acquisition-by-chroma-medicine-forming-transatlantic-pioneer-in-epigenetic-editing2022-01-06T16:09:43Z https://sofinnovapartners.com/news/dmc-announces-first-close-of-series-b-financing-raising-usd34-million2022-01-06T16:09:44Z https://sofinnovapartners.com/news/meiogenix-announces-usd13-million-series-a-financing-round-led-by-sofinnova-partners2022-01-06T16:09:45Z https://sofinnovapartners.com/news/sofinnova-partners-announces-a-new-investment-from-its-medtech-acceleration-fund2023-10-20T17:13:10Z https://sofinnovapartners.com/news/pixium-vision-receives-french-regulatory-authority-ansm-approval-to-initiate-european-primavera-pivotal-study-of-prima-system2022-01-06T16:09:47Z https://sofinnovapartners.com/news/michelin-and-pyrowave-join-forces-to-industrialize-an-innovative-plastic-waste-recycling-technology2022-01-06T16:09:48Z https://sofinnovapartners.com/news/tissium-receives-fda-investigational-device-exemption-for-vascular-sealant2022-01-06T16:09:49Z https://sofinnovapartners.com/news/myricx-pharma-launches-with-4.5m-financing-to-progress-its-novel-nmt-inhibitors-in-cancer2022-01-06T16:09:50Z https://sofinnovapartners.com/news/sofinnova-partners-raises-472-548-million-to-form-largest-early-stage-healthcare-vc-fund-in-europe2022-01-06T16:09:51Z https://sofinnovapartners.com/news/calliditas-announces-positive-topline-results-from-pivotal-phase-3-nefigard-trial2022-01-06T16:09:52Z https://sofinnovapartners.com/news/gensight-biologics-reports-validation-of-lumevoq-marketing-authorisation-application-maa-by-european-medicines-agency2022-03-15T09:53:56Z https://sofinnovapartners.com/news/inventiva-announces-the-publication-of-a-scientific-paper-on-the-role-of-ppars-in-the-treatment-of-nash-in-the-medical-journal-nature-review-gastroenterology-hepatology2022-03-15T09:55:54Z https://sofinnovapartners.com/news/redx-pharma-announces-appointment-of-leading-oncology-drug-developer-dr-jane-robertson-as-chief-medical-officer2023-09-05T12:59:56Z https://sofinnovapartners.com/news/gensight-biologics-successfully-raises-25-million-in-an-oversubscribed-private-placement-with-us-and-european-institutional-investors2022-03-15T09:56:34Z https://sofinnovapartners.com/news/cincor-pharma-announces-first-patient-dosed-with-cin-107-in-phase-2-study-in-treatment-resistant-hypertensive-subjects2022-03-15T09:57:56Z https://sofinnovapartners.com/news/dr.-joe-anderson-joins-sofinnova-partners2022-03-15T09:59:31Z https://sofinnovapartners.com/news/inventiva-receives-fda-breakthrough-therapy-designation-for-lead-drug-candidate-lanifibranor-in-nash2022-03-15T10:04:08Z https://sofinnovapartners.com/news/afyren-appoints-stefan-borgas-as-chairman-of-the-board2022-03-15T10:05:00Z https://sofinnovapartners.com/news/proqr-appoints-naveed-shams-md-phd-as-chief-scientific-officer2022-03-15T10:05:55Z https://sofinnovapartners.com/news/cincor-pharma-raises-143-million-in-series-b-financing2022-01-06T16:10:02Z https://sofinnovapartners.com/news/the-european-house-ambrosetti-and-sofinnova-partners-announce-the-hosting-of-bioequity-europe-2022-in-milan-italy2022-01-06T16:10:03Z https://sofinnovapartners.com/news/biotalys-awarded-1.1-million-vlaio-research-grant2024-04-02T06:43:04Z https://sofinnovapartners.com/news/reflexion-and-sofinnova-partners-recognized-with-salus-excellence-award-at-the-convergence-in-oncology-summit2022-03-15T10:10:08Z https://sofinnovapartners.com/news/sensorion-successfully-raises-approximately-31-million-in-an-oversubscribed-private-placement-to-us-and-european-investors2022-03-15T10:10:41Z https://sofinnovapartners.com/news/gradient-denervation-technologies-raises-3.5m-in-seed-funding-with-sofinnova-partners2022-03-15T10:10:56Z https://sofinnovapartners.com/news/biotalys-honored-with-two-agtech-breakthrough-awards2024-04-02T06:43:50Z https://sofinnovapartners.com/news/redx-announces-new-research-collaboration-with-jazz-pharmaceuticals-to-discover-and-develop-two-targeted-cancer-therapies2023-09-05T12:59:45Z https://sofinnovapartners.com/news/calliditas-announces-agreement-to-acquire-controlling-interest-in-genkyotex-sa2022-03-15T10:16:50Z https://sofinnovapartners.com/news/appointment-of-non-executive-director-and-changes-to-board-committees2023-09-05T12:59:25Z https://sofinnovapartners.com/news/iomx-therapeutics-raises-eur-65-million-in-series-b-round2022-01-06T16:10:14Z https://sofinnovapartners.com/news/redx-signs-out-licensing-agreement-with-astrazeneca2023-09-05T12:59:11Z https://sofinnovapartners.com/news/corvent-medical-appoints-richard-s.-walsh-as-chief-executive-officer2022-03-15T10:21:58Z https://sofinnovapartners.com/news/genespire-appoints-jörn-aldag-as-chairman-of-the-board-of-directors2022-03-15T10:23:24Z https://sofinnovapartners.com/news/dna-script-expands-series-b-to-89m2022-03-15T10:24:17Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-raises-28-million-in-series-a-financing-to-advance-restorative-therapy-for-type-1-diabetes-and-inflammatory-bowel-disease2022-03-15T10:26:08Z https://sofinnovapartners.com/news/inotrem-receives-clearance-from-french-belgian-and-us-authorities-to-launch-a-phase-ii-clinical-trial2022-03-15T10:27:20Z https://sofinnovapartners.com/news/proqr-strengthens-scientific-advisory-board-with-leaders-in-inherited-retinal-disease-and-rna-therapy2022-03-15T10:28:26Z https://sofinnovapartners.com/news/corwave-awarded-2.5m-from-the-european-commission-through-the-eic-accelerator-program2022-03-15T10:28:50Z https://sofinnovapartners.com/news/shockwave-appoints-maria-sainz-to-board-of-directors2022-03-15T10:30:15Z https://sofinnovapartners.com/news/verona-pharma-raises-200-million-in-oversubscribed-private-placement-and-subscription2023-08-24T16:03:43Z https://sofinnovapartners.com/news/afyren-lists-on-euronext-growth-paris2022-01-06T16:10:26Z https://sofinnovapartners.com/news/comet-bio-wins-start-up-of-the-year-nutraingredients-award-for-20202022-03-15T10:33:00Z https://sofinnovapartners.com/news/venus-medtech-to-partner-with-pi-cardia-to-bring-its-leaflex-aortic-valve-technology-to-china2022-03-15T10:34:33Z https://sofinnovapartners.com/news/inventiva-announces-the-pricing-of-its-initial-public-offering-on-the-nasdaq-global-market2022-03-15T10:35:45Z https://sofinnovapartners.com/news/biotalys-appoints-wim-ottevaere-as-chief-financial-officer-in-preparation-for-global-growth2024-04-02T06:44:05Z https://sofinnovapartners.com/news/reflexion-and-telix-pharmaceuticals-announce-strategic-collaboration-for-treatment-of-high-risk-cancers2022-03-15T10:38:47Z https://sofinnovapartners.com/news/success-of-the-capital-increase-with-pre-emptive-subscription-rights-7.3-million-raised-to-finance-the-prima-system-primavera-pivotal-study2022-03-15T10:42:06Z https://sofinnovapartners.com/news/sensorion-appoints-dr-edwin-moses-former-ablynx-ceo-as-chairman-of-the-board2022-03-15T10:43:41Z https://sofinnovapartners.com/news/mastor-secures-seed-funding-from-sofinnova-partners-to-develop-its-laparoscopy-assistance-platform2022-03-15T10:44:57Z https://sofinnovapartners.com/news/sofinnova-partners-announces-two-first-investments-from-its-md-start-iii-medtech-acceleration-fund2023-10-20T17:13:35Z https://sofinnovapartners.com/news/redx-pharma-proposed-financing-of-30-million-via-issue-of-convertible-loan-notes-and-share-subscription-and-notice-of-general-meeting2023-09-05T12:58:57Z https://sofinnovapartners.com/news/tissium-raises-50m-in-series-c-financing-to-propel-its-platform-to-commercial-stage2022-01-06T16:10:39Z https://sofinnovapartners.com/news/elsan-partners-with-sofinnova-md-start-iii-an-acceleration-fund-dedicated-to-healthcare-innovation-and-medical-devices2023-10-20T17:13:22Z https://sofinnovapartners.com/news/mainstay-medical-announces-u.s.-fda-approval-of-reactiv8-neurostimulation-system-for-chronic-low-back-pain2022-03-15T10:57:18Z https://sofinnovapartners.com/news/shockwave-announces-pricing-of-public-offering-of-common-stock2022-03-15T10:59:23Z https://sofinnovapartners.com/news/inventivas-lanifibranor-meets-the-primary-and-key-secondary-endpoints-in-the-phase-iib-native-clinical-trial-in-non-alcoholic-steatohepatitis-nash2022-03-15T10:59:53Z https://sofinnovapartners.com/news/epsilen-bio-appoints-julia-berretta-as-chief-executive-officer-and-mathieu-simon-as-chairman-of-the-board2022-03-15T12:58:36Z https://sofinnovapartners.com/news/synthace-and-tecan-announce-collaboration-to-accelerate-purification-optimization-in-process-development-through-augmented-lab-automation2023-09-05T12:56:51Z https://sofinnovapartners.com/news/sofinnova-partners-announces-sale-of-corvidia-therapeutics-to-novo-nordisk2025-09-02T15:37:56Z https://sofinnovapartners.com/news/afyren-and-the-after-biochem-european-consortium-obtain-a-funding-of-20-million-euros-for-the-industrial-production-of-new-bio-based-products2022-03-15T13:01:22Z https://sofinnovapartners.com/news/protera-closes-5.6m-series-a-financing-led-by-sofinnova-partners2022-03-15T13:01:45Z https://sofinnovapartners.com/news/biotalys-expands-executive-team-and-establishes-u.s.-headquarters-to-strengthen-north-american-presence2024-07-01T10:42:10Z https://sofinnovapartners.com/about2024-04-02T06:30:51Z https://sofinnovapartners.com/news2026-04-14T07:32:31Z https://sofinnovapartners.com/portfolio2022-01-03T11:31:30Z https://sofinnovapartners.com/contact2022-03-04T08:52:18Z https://sofinnovapartners.com/strategy2023-09-05T17:34:44Z https://sofinnovapartners.com2025-12-12T17:58:23Z https://sofinnovapartners.com/esg2026-03-11T17:02:14Z https://sofinnovapartners.com/submit2022-03-04T08:52:37Z https://sofinnovapartners.com/team2024-08-30T14:00:06Z https://sofinnovapartners.com/news/why-is-fundraising-by-women-so-much-harder2022-01-06T16:10:51Z https://sofinnovapartners.com/portfolio/calliditas2026-01-29T09:02:59Z https://sofinnovapartners.com/portfolio/hotspot2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/tm3-therapeutics2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/safeheal2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/micropep2024-04-02T06:24:30Z https://sofinnovapartners.com/portfolio/biotalys2025-12-12T18:32:57Z https://sofinnovapartners.com/portfolio/dna-script2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/iomx2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/gecko-biomedical-22022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/comet-biorefining2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/shockwave-medical2024-08-07T12:41:13Z https://sofinnovapartners.com/portfolio/avantium2024-04-02T06:31:26Z https://sofinnovapartners.com/portfolio/hookipa-pharma2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/cerenis-therapeutics2024-04-02T06:31:41Z https://sofinnovapartners.com/portfolio/recor-medical2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/preglem2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/ethycal-oncologie-science2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/corevalve2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/genset-sa2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/protera2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/sitryx2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/quince-therapeutics-formerly-erydel2025-12-12T18:04:48Z https://sofinnovapartners.com/portfolio/nodthera2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/inventiva2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/highlife2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/enyo-pharma-32022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/asceneuron-22025-05-07T16:29:42Z https://sofinnovapartners.com/portfolio/reflexion-medical2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/inotrem2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/cellucomp2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/proqr-22022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/nucana-biomed2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/mission-therapeutics2024-07-25T11:03:39Z https://sofinnovapartners.com/portfolio/mainstay-medical2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/crescendo-biologics-22022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/noxxon-pharma-ag2024-04-02T06:29:40Z https://sofinnovapartners.com/portfolio/breath-therapeutics2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/delinia2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/glycovaxyn2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/omthera-pharmaceuticals2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/ascendis-pharma-as2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/movetis2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/dbv-technologies2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/addex-therapeutics2023-09-05T17:32:22Z https://sofinnovapartners.com/portfolio/innate-pharma-sa2024-04-02T06:31:54Z https://sofinnovapartners.com/portfolio/biosyntia2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/enginzyme2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/pincell2025-07-07T14:35:14Z https://sofinnovapartners.com/portfolio/genespire2024-09-06T13:39:57Z https://sofinnovapartners.com/portfolio/maxcyte2023-09-05T13:04:47Z https://sofinnovapartners.com/portfolio/moon-surgical2023-06-23T09:16:47Z https://sofinnovapartners.com/portfolio/nitrase-therapeutics2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/enthera2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/myricx-pharma2024-05-22T09:38:05Z https://sofinnovapartners.com/portfolio/catamaran-bio2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/redxpharma2023-10-03T10:29:04Z https://sofinnovapartners.com/portfolio/noema-pharma2022-01-03T11:31:33Z